0001213900-21-002805.txt : 20210119 0001213900-21-002805.hdr.sgml : 20210119 20210119151550 ACCESSION NUMBER: 0001213900-21-002805 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20201130 FILED AS OF DATE: 20210119 DATE AS OF CHANGE: 20210119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURA SYSTEMS INC CENTRAL INDEX KEY: 0000826253 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 954106894 STATE OF INCORPORATION: DE FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-17249 FILM NUMBER: 21535259 BUSINESS ADDRESS: STREET 1: 10541 ASHDALE STREET CITY: STANTON STATE: CA ZIP: 90680 BUSINESS PHONE: 3106435300 MAIL ADDRESS: STREET 1: 10541 ASHDALE STREET CITY: STANTON STATE: CA ZIP: 90680 10-Q 1 f10q1120_aurasystemsinc.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to ______________

AURA SYSTEMS, INC.

(Exact name of Registrant as specified in its charter)

Delaware		95-4106894
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

10541 Ashdale Street

Stanton, CA 90680

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (310) 643-5300

Former name, former address and former fiscal year, if changed since last report:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: YES ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES ☐ NO ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ☐		Accelerated Filer ☐
Non-accelerated filer ☒		Smaller Reporting Company ☒
		Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered

Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock, as of the latest practicable date.

Class		Outstanding November 30, 2020
Common Stock, par value $0.0001 per share		64,518,512 shares

AURA SYSTEMS, INC.

INDEX

Index			Page No.

PART I. FINANCIAL INFORMATION			1

	ITEM 1.	Financial Statements (Unaudited)	1

		Condensed Balance Sheets as of November 30, 2020 and February 29, 2020	1

		Condensed Statements of Operations for the Three and Nine months ended November 30, 2020 and 2019	2

		Condensed Statements of Cash Flows for the Nine months ended November 30, 2020 and 2019	3

		Statements of Changes in Shareholders’ Deficit	4

		Notes to Financial Statements	5

	ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15

	ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	21

	ITEM 4.	Controls and Procedures	21

PART II. OTHER INFORMATION			22

	ITEM 1.	Legal Proceedings	22

	ITEM 1A.	Risk Factors	23

	ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23

	ITEM 3.	Defaults Upon Senior Securities	23

	ITEM 4.	Mine Safety Disclosures	24

	ITEM 5.	Other Information	24

	ITEM 6.	Exhibits	24

SIGNATURES AND CERTIFICATIONS			25

ITEM 1. FINANCIAL STATEMENTS

AURA SYSTEMS, INC.

CONDENSED BALANCE SHEETS

(Unaudited)

	November 30, 2020			February 29, 2020
Assets
Current assets
Cash and cash equivalents	$	143,693		$	19,807
Inventory		105,166			90,037
Other current assets		35,787			1,487
Total current assets		284,645			111,330
Fixed Assets, net		8,624			-
Total assets	$	293,269		$	111,330

Liabilities & Shareholders’ Deficit
Current liabilities
Accounts payable	$	1,873,745		$	2,537,061
Accrued expenses		730,588			1,946,290
Customer advances		440,331			440,331
Accrued expense-related party		-			1,008,328
Accrued interest-notes payable-related party		375,925			262,911
Accrued interest-notes payable		217,395			498,698
Notes payable, current portion		189,116			983,717
Notes payable and accrued interest-related party		11,960,097			11,333,960
Total current liabilities		15,787,197			19,011,296
Notes payable-related party		3,000,000			3,000,000
Notes payable		197,725			0
Convertible notes payable		1,402,971			1,402,971
Total liabilities		20,387,894			23,414,267

Commitments and contingencies (note 7)		-			-

Shareholders’ deficit
Common stock: $0.0001 par value; 150,000,000 shares authorized at November 30 and February 29, 2020; 64,518,512 and 56,400,874 issued and outstanding at November 30 and February 29, 2020, respectively		6,450			5,639
Additional paid-in capital		445,097,390			443,417,452
Accumulated deficit		(465,198,465	)		(466,726,027	)
Total shareholders’ deficit		(20,094,625	)		(23,302,937	)
Total liabilities and shareholders’ deficit	$	293,269		$	111,330

The accompanying notes are an integral part of these unaudited financial statements.

AURA SYSTEMS, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	Three-Months Ended November 30,						Nine-months Ended November 30,
	2020			2019			2020			2019
				(restated)						(restated)
Net revenue	$	7,829		$	396,775		$	61,462		$	744,850
Cost of goods sold		5,320			115,655			46,718			147,752
Gross profit		2,510			281,119			14,743			597,097
Operating expenses
Engineering, research & development		70,217			30,472			169,318			123,024
Selling, general & administration		258,528			407,652			1,034,836			915,934
Total operating expenses		328,744			438,124			1,204,154			1,038,958
Loss from operations		(326,235	)		(157,005	)		(1,189,411	)		(441,861	)
Other (income) expense:
Interest expense, net		268,017			283,928			884,751			885,731
Other income		(4,391	)		(107	)		(2,683,805	)		(107	)
Gain on extinguishment of debt		-			-			(871,887	)		-
Other (gains) losses from settlements		(32	)		333,512			(46,032	)		333,512
Income (loss) before income tax provision		(589,829	)		(774,337	)		1,527,562			(1,660,997	)
Income tax provision		-			-			-			-
Net income (loss)	$	(589,829	)	$	(774,337	)	$	1,527,562		$	(1,660,997	)

Basic income (loss) per share	$	(0.01	)	$	(0.01	)	$	0.03		$	(0.03	)
Weighted average shares outstanding-basic		62,664,666			55,296,222			59,803,498			54,012,831
Dilutive income (loss) per share	$	(0.01	)	$	(0.01	)	$	0.03		$	(0.03	)
Weighted average shares outstanding-dilutive		62,664,666			55,296,222			61,183,610			54,012,831

See accompanying notes to these unaudited financial statements.

AURA SYSTEMS, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine-Months Ended November 30,
	2020			2019
				(restated)
Net income (loss)	$	1,527,562		$	(1,660,996	)
Adjustments to reconcile net income (loss) to cash used in operating activities
Loss on settlement of debt		-			329,723
Depreciation of fixed assets		297			-
Stock-based compensation expense		193,750			-
Gain on write-off of expired liabilities		(3,585,639	)		-
Changes in working capital assets and liabilities:					-
Inventory		(15,129	)		(53,163	)
Other current assets		(34,300	)		8,357
Accrued interest on notes payable		847,987			855,534
Accts payable, customer deposits and accrued expenses		(181,026	)		29,966
Cash used in operating activities		(1,246,498	)		(490,579	)

Cash flows from investing activities:
Purchase of property, plant and equipment		(8,921	)		-

Cash flows from financing activities:
Issuance of common stock		1,220,000			295,245
Payment on notes payable		(65,000	)		(40,000	)
Proceeds from Federal PPP & SBA notes		224,305			-
Cash provided by financing activities		1,379,305			255,245

Net decrease in cash and cash equivalents		123,886			(235,334	)
Beginning cash		19,807			358,209
Ending cash	$	143,693		$	122,875
Cash paid in the period for:
Interest	$	2,500		$	-
Income taxes	$	-		$	-
Supplemental schedule of non-cash transactions:
Note payable converted into shares of common stock	$	267,000		$	13,159
Convertible notes converted into shares of common stock	$	-		$	20,501

See accompanying notes to these unaudited financial statements.

AURA SYSTEMS INC.

CONDENSED STATEMENTS OF SHAREHOLDERS’ DEFICIT

(Unaudited)

	Common Stock Shares			Common Stock Amount			Additional Paid-In Capital		Accumulated Deficit			Total Shareholders’ Deficit
Balance, February 28, 2019		53,714,145		$	5,371		$	442,519,092	$	(464,119,162	)	$	(21,594,699	)
Shares issued for cash		156,250			15			49,985					50,000
Net loss		-			-			-		(675,321	)		(675,321	)
Balance, May 31, 2019		53,870,395		$	5,386		$	442,569,077	$	(464,794,483	)	$	(22,220,020	)
Shares issued for cash		501,765			51			100,302		-			100,353
Shares issued for settlement		1,030,385			103			329,620		-			329,723
Net loss		-			-			-		(211,339	)		(211,339	)
Balance, August 31, 2019		55,402,545		$	5,540		$	442,998,999	$	(465,005,822	)	$	(22,001,283	)
Shares issued for cash		725,000			73			144,928		-			145,001
Shares cancelled		(1,065,051	)		(107	)		-		-			(107	)
Shares issued for debt		168,380			16			33,642		-			33,658
Net loss (restated)		-			-			-		(774,337	)		(774,337	)
Balance, November 30, 2019 (restated)		55,230,874		$	5,522		$	443,177,569	$	(465,780,159	)	$	(22,597,068	)

Balance, February 29, 2020		56,400,874			5,641			443,417,449		(466,726,027	)		(23,302,938	)
Shares issued for cash		1,358,333			135			234,865		-			235,000
Stock-based compensation expense		-			-			77,599		-			77,599
Net loss		-			-			-		(606,001	)		(606,001	)
Balance, May 31, 2020		57,759,207			5,776			443,729,913		(467,332,029	)		(23,596,340	)
Shares issued for cash		3,866,665			387			579,613		-			580,000
Shares issued for settlement		192,641			19			266,981		-			267,000
Stock-based compensation expense		-			-			96,476		-			96,476
Net income		-			-			-		2,723,392			2,723,392
Balance, August 31, 2020		61,818,513			6,182			444,672,983		(464,608,637	)		(19,929,472	)
Shares issued for cash		2,699,999			270			404,730		-			405,000
Stock-based compensation expense		-			-			19,674		-			19,674
Net loss		-			-			-		(589,829	)		(589,829	)
Balance, November 30, 2020		64,518,512			6,452			445,097,387		(465,198,466	)		(20,094,627	)

See accompanying notes to these unaudited financial statements.

AURA SYSTEMS, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(Unaudited)

NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Aura Systems, Inc., (“Aura”, “We” or the “Company”) a Delaware corporation, was founded to engage in the development, commercialization, and sale of products, systems, and components, using its patented and proprietary electromagnetic technology. Aura develops and sells AuraGen^®axial flux mobile induction power systems to the industrial, commercial, and defense mobile power generation markets.

Basis of Presentation

In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. However, the results of operations included in such financial statements may not necessary be indicative of annual results.

The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended February 29, 2020 (“Fiscal 2020”) filed with the Securities and Exchange Commission (“SEC”) on July 13, 2020 (“2020 Form 10-K.”).

The Company amended its Quarterly Report on Form 10-Q for the period ended November 30, 2019, filed with the SEC on January 14, 2020, solely for the purpose of restating the financial statements (unaudited) and the accompanying notes to the financials due to certain adjustments that were recorded in the fourth quarter ended February 29, 2020; however, to ensure comparability in year-to-year comparisons, these adjustments were restated to the third quarter of Fiscal 2020. The condensed financial statements in his Quarterly Report for the three and nine-months ended November 30, 2020 include the effect of the restatements.

Our fiscal year ends on the last day of February. Accordingly, the current fiscal year is ending on February 28, 2021; we refer to the current fiscal as (“Fiscal 2021”). The prior fiscal year is Fiscal 2020.

Significant Accounting Policies

For a detailed discussion about the Company’s significant accounting policies, refer to Note 2 — “Summary of Significant Accounting Policies,” in our financial statements included in Company’s 2020 Form 10-K. During the three and nine-months ended November 30, 2020, the Company recognized aggregate gains of approximately $2.7 million in connection with the cancellation of certain accounts payable balances and accrued payroll related to unpaid wages and salaries and approximately $0.9 million in connection with demand promissory notes with three persons for which the respective statute of limitations periods have expired.

Earnings Per Share

The following table sets forth the basic and dilutive earnings per share for the nine-months ended November 30, 2020. The dilutive earning per share includes only the dilutive incremental effect of additional shares issued on an “as if converted basis” in relation to the convertible notes payable principal amounts outstanding as of November 30, 2020 (see Notes 3 and 6). The three-months ended November 30, 2020 was not included in the following table as the effect is anti-dilutive.

	Nine-Months Ended November 30, 2020
	Income		Shares		Per-share
	(Numerator)		(denominator)		Amount
Basic EPS
Income available to common stockholders	$	1,527,562		59,803,498	$	0.03

Effect of Dilutive Securities
Convertible notes payable	$	17,155		1,380,112	$	0.01

Dilutive EPS
Income available to common stockholders plus assumed conversions	$	1,544,716		61,183,610	$	0.03

Use of Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current year presentation.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued Accounting Standards Update 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instrument. Subsequent to the issuance of ASU 2016-13, the FASB clarified the guidance through several ASUs. The collective new guidance (ASC 326) generally requires entities to use a current expected credit loss model, which is a new impairment model based on expected losses rather than incurred losses. Under this model, an entity would recognize an impairment allowance equal to its current estimate of all contractual cash flows that the entity does not expect to collect. The entity’s estimate would consider relevant information about past events, current conditions, and reasonable and supportable forecasts. ASC 326 is effective for annual and interim fiscal reporting periods beginning after December 15, 2022, with early adoption permitted for annual reporting periods beginning after December 15, 2018. The Company is continuing to evaluate the expected impact of this ASC 326 but does not expect it to have a material impact on its financial statements upon adoption.

NOTE 2 – GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company is reporting in this Quarterly Report operating losses of approximately $326,000 and $1,189,000 for the three and nine-months ended November 30, 2020, respectively, and negative cash flow from operating activities of approximately $1,246,000 for the nine-months ended November 30, 2020; such factors raise substantial doubt about the Company’s ability to continue as a going concern.

If the Company is unable to generate profits on a sustained basis and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether.

Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to retain its current financing, to obtain additional financing, and ultimately to attain profitability.

Beginning with the second quarter of Fiscal 2020, we increased operations of our AuraGen^®/VIPER business and revenue for the three and nine-months ended November 30, 2020 of Fiscal 2021 was approximately $7,800 and $61,000, respectively, as compared to approximately $397,000 and $745,000 of revenue in the comparable periods of Fiscal 2020.

NOTE 3 – NOTES PAYABLE

Non-related party and related party notes payable principal and accrued interest amounts consisted of the following:

Non-Related Party Promissory Notes (see below)	November 30, 2020			February 29, 2020

Demand promissory notes payable with 1 and 4 individuals as of November 30, 2020 and February 29, 2020, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)	$	10,000		$	768,537
Messrs. Abdou notes payable		150,181			215,181
U.S. Payroll Protection Plan loan program		74,405			-
U.S. Small Business Administration-Economic Injury Disaster Loan		152,256			-
Total Demand and Notes Payable		386,842			983,718
Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.		264,462			264,462
Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.		133,178			133,178
Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.		945,825			945,825
Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.		59,506			59,506
Total Convertible Promissory Notes		1,402,971			1,402,971
Accrued Interest - convertible, demand and notes payable		217,972			498,698
Total Non-Related Party		2,007,785			2,885,387

Notes Payable-Related Party (see Note 6)
Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details		3,375,925			3,262,911
Kopple Notes Payable-related party, see Kopple Notes, Note 6:		11,114,892			10,494,933
Mel Gagerman Notes Payable, see Gagerman, Note 6:		144,628			139,026
On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.		700,000			700,000
Total Related Party		15,335,444			14,596,871
Total notes payable and accrued interest		17,343,229			17,482,258
Less: Current portion	$	(12,742,533	)	$	(12,816,376	)
Long-term portion	$	4,600,696		$	4,665,882

Demand Promissory Notes and Notes Payable

Demand promissory notes as of November 30 and February 29, 2020 are for one and four individuals, respectively, issued in September 2015 that are payable on demand with an interest rate of 10% per annum. As of November 30, 2020, the one individual is for the principal amount owed to the Mr. Zeitlin, a former director of the Company, of $10,000.

In the nine-months ended November 30, 2020, $758,537 of demand notes principal and $385,349 of accrued interest were reversed as the related statute of limitations were determined to have expired. This reversal resulted in an aggregate reduction of current liabilities of $1,143,886, the recording of an issuance of 192,641 shares of common stock on the Condensed Balance Sheet as of November 30, 2020, and the recognition of $871,887 as gain on extinguishment of debt on the Condensed Statements of Operations for the nine-months ended November 30, 2020.

Abdou and Abdou

On June 20, 2013, the Company entered into an agreement with two individuals, Mr. M. Abdou and Mr. W. Abdou, for the sale of $125,000 of secured convertible notes payable (the “Notes”) and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $24,470 as a discount, which has been fully amortized. There is a remaining balance of $125,000 as of February 28, 2019. In 2016, the Company and the Company’s former Chief Executive Officer, Melvin Gagerman, were named among several other defendants in a lawsuit filed by Messrs. Abdou demanding repayment of loans totaling $125,000 plus accrued interest and exemplary damages. In January 2017, the Company entered into an agreement with all secured creditors other than Mr. W. Abdou and Mr. M. Abdou. In September 2018, the court entered a judgment of approximately $235,000 plus legal fees of in favor of the Messrs. Abdou. The Company subsequently appealed this judgment and, in September 2019, reached a settlement agreement with these creditors for a principal amount of $325,000, of which approximately $150,000 and $215,000 were outstanding as of November 30 and February 29, 2020, respectively.

Paycheck Protection Plan Loan

During April 2020, the Company ceased operations for approximately 6 weeks in compliance with State of California and the County of Orange public health pronouncements associated with the COVID-19 pandemic. On April 23, 2020, we obtained a Paycheck Protection Program (“PPP”) loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company intends to use the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. While we intend to apply for the forgiveness of the PPP Loan, there is no assurance that we will obtain forgiveness of the PPP Loan in whole or in part. As of November 30, 2020, $24,802 was classified as notes payable, non-current and $49,603 was classified as part of notes payable, current portion.

Economic Injury Disaster Loan

Entities negatively impacted by the COVID-19 pandemic were eligible to apply for loans sponsored by the United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL Loan”) program. On July 1, 2020, the Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; and there is no prepayment penalty or fees. As of November 30, 2020, the amount outstanding including accrued interest of $2,356 is $152,256 and is classified as part of notes payable, non-current on the November 30, 2020 balance sheet.

Convertible Notes Payable

Kenmont Capital Partners

On May 7, 2013, the Company transferred 4 notes payable with a total principal value of $1,000,000 together with accrued interest, and consulting fees to a senior secured convertible note with a principal value of $1,087,000 (“New Kenmont Note”) and warrants to Kenmont Capital Partners LP. The New Kenmont Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. The Company recorded $342,020 as a discount, which has been fully amortized. There was a remaining balance of $549,954 as of November 30 and February 29, 2020, respectively.

LPD Investments

On May 7, 2013, the Company transferred 2 note payables with a total principal value of $550,000 together with accrued interest to a senior secured convertible note with a principal value of $558,700 (“New LPD Note”) and warrants to LPD Investments, Ltd. The New LPD Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. The Company recorded $175,793 as a discount, which has been fully amortized. There is a remaining balance of $163,677 as of November 30 and February 29, 2020, respectively.

Guenther

On May 7, 2013, the Company entered into an agreement with an individual, Mr. Guenther, for the sale of $750,000 of secured convertible note payable (the “Note”) and warrants. The Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants entitle the holder to acquire 1,000,000 shares and have an initial exercise price of $0.75 per share and have a 7-year term. The Company recorded $235,985 as a discount, which has been fully amortized. There is a remaining balance of $232,194 as of November 30 and February 29, 2020, respectively.

Dresner and Lempert

On June 20, 2013, the Company entered into an agreement with two individuals, Mr. Dresner and Dr. Lempert, for the sale of $200,000 of secured convertible notes payable (the “Notes”) and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $39,152 as a discount, which has been fully amortized. During Fiscal 2020, Dr. Lempert converted his share of the amount outstanding into common shares and the balance outstanding of $59,506 as of November 30 and February 29, 2020, respectively, is for Dresner exclusively.

Dalrymple – August 2012

On August 10, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $1,000,000 of unsecured Convertible Promissory Note. The Convertible Promissory Note balance together with all accrued interest thereon was due and payable on August 10, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%. The Company recorded $310,723 as a debt discount, which will be amortized over the life of the note. There is a remaining balance of $264,462 as of November 30 and February 29, 2020, respectively.

Dalrymple – October 2012

On October 2, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $500,000 of unsecured Convertible Promissory Note. This Convertible Promissory Note balance together with all accrued interest thereon was due and payable on October 2, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%. The Company recorded $137,583 as a debt discount, which will be amortized over the life of the note. There is a remaining balance of $133,178 as of November 30 and February 29, 2020, respectively.

On January 30, 2017, the Company entered into an agreement entitled First Amendment to Transaction Documents with five of seven secured creditors holding a security interest in all of the Company’s assets except for its patents and other intellectual properties. All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a “Required Cash Payment” as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of November 30 and February 29, 2020, respectively, plus any outstanding accrued interest.

NOTE 4 – ACCRUED EXPENSES

Accrued expenses consisted of the following as of the period referenced below:

	November 30, 2020		February 29, 2020
Accrued payroll and related expenses	$	634,114	$	1,868,928
Accrued legal expenses		20,000		-
Income taxes payable		27,035		27,035
Other accrued expenses		49,439		50,327
	$	730,588	$	1,946,290

Accrued payroll and related expenses consist primarily of salaries and vacation time accrued but not paid to employees due to our lack of financial resources. In the second quarter of fiscal year 2021, liabilities with respect to approximately $1.3 million in accrued payroll and related expenses were reversed as the related statute of limitation periods were determined to have expired.

NOTE 5 – SHAREHOLDERS’ EQUITY

Common Stock

During the three and nine-months ended November 30, 2020, the Company issued approximately 2,700,000 and 7,925,000 shares of common stock, respectively, for $405,000 and $1,220,000 in cash, respectively. During the three and nine-months ended November 30, 2019, the Company issued approximately 725,000 and 1,383,015 shares of common stock, respectively, for $144,980 and $295,333 in cash, respectively. During August 2019, 1,030,385 shares were issued for a settlement valued at $329,723 and during August 2020, 192,641 shares were issued in connection with the Veen settlement (see Note 3). In November 2019, 168,380 shares of common stock were issued to investors in settlement of debt and accrued interest valued at approximately $34,000.

Employee Options and Warrants

The 2006 Employee Stock Option Plan

In September 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan, subject to shareholder approval, which was obtained at a special shareholders meeting in 2009. Under the 2006 Plan, the Company may grant options for up to the greater of three million or 10% of the number of shares of the Common Stock of Aura from time to time outstanding. As of February 29, 2020, and November 30, 2020, there were no stock options outstanding.

The 2011 Director and Executive Officers Stock Option Plan

In October 2011, shareholders approved the 2011 Director and Executive Officers Stock Option Plan at the Company’s annual meeting. Under the 2011 Plan, the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the nine-months ended November 30, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant. The following table provides the assumptions required to apply the Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date:

	Options Issued During the Nine-Months ended November 30, 2020

Exercise Price	$	0.25
Share Price	$	0.16
Volatility %		225	%
Risk-free rate		0.57	%
Expected term (yrs.)		4.0

The aggregate fair value of the 1,250,000 options granted in March 2020 is approximately $194,000, or $0.155 per option, with $18,875 and $193,750 recorded as part of sales, general and administration expense during the three and nine-months ended November 30, 2020, respectively. No stock-based compensation expense was recorded during Fiscal 2020.

The following tables provide additional information regarding stock options outstanding and exercisable under the 2011 Director and Executive Officers Stock Option Plan:

	Number of Shares		Exercise Price		Weighted Average Intrinsic Value
Outstanding, February 29, 2020		1,040,001	$	1.40	$	-
Granted		1,250,000		0.25		-
Exrecised		-		-		-
Cancelled		-		-		-
Outstanding, November 30, 2020		2,290,001	$	0.77	$	-

Range of Exercise Price				Stock Options Outstanding				Stock Options Exercisable				Weighted Average Remaining Contractual Life		Weighted Average Exercise Price of Options Outstanding				Weighted Average Exercise Price of Options Exercisable
$	0.25 to $1.40				2,290,001				2,290,001			3.25 Yrs.		$	0.77			$	0.77

Warrants

Historically, warrants have been issued to investors and others for services and enticements to invest funds with the Company. Generally, these warrants fully vest immediately or within a 90-day period from the date of grant and have an expiration date of five-years from the date of grant. With grants dated prior to Fiscal 2021, an exercise price of $1.40 has been used with all warrants. No warrants were issued in the nine-months ended November 30, 2020.

Activity in issued and outstanding warrants is as follows for the nine-months ended November 30, 2020:

	Number of Shares		Exercise Price
Outstanding, February 29, 2020		5,816,939	$	1.40
Granted		-		-
Exrecised		-		-
Cancelled		-		-
Outstanding, November 30, 2020		5,816,939	$	1.40

Other information related to the warrants outstanding and exercisable as of November 30, 2020 follows:

Range of Exercise Price				Stock Warrants Outstanding				Stock Warrants Exercisable				Weighted Average Remaining Contractual Life				Weighted Average Exercise Price of Warrants Outstanding				Weighted Average Exercise Price of Warrants Exercisable
$	1.40				5,816,939				5,816,939				2.19 Yrs.			$	1.40			$	1.40

NOTE 6 – RELATED PARTIES TRANSACTIONS

Notes payable-related party, non-current - $3,000,000 on the condensed balance sheets as of November 30 and February 29, 2020 consists of the Breslow Note as described below:

Breslow Note

On January 24, 2017, the Company entered into a Debt Refinancing Agreement with Mr. Breslow, a former Director of the Company. Pursuant to the agreement, both Mr. Breslow and the Company acknowledged that total debt owed to Mr. Breslow was $23,872,614 including $8,890,574 of accrued interest. Mr. Breslow agreed to cancel and forgive all interest due, waive all events of default and sign a new five-year convertible note in the amount of $14,982,041 providing for no interest for six months and interest of 5% per annum thereafter payable monthly in arrears. The note also provides various default provisions. In accordance with the agreement, on February 14, 2018, the effective date of the 1-for-7 reverse stock split, $11,982,041 of the note was converted into 7,403,705 shares of common stock and the then accrued interest of $9,388,338 was forgiven. A new $3,000,000 convertible five-year note representing the remaining balance was entered into at a conversion rate of $1.40. The note bears interest at a rate of 5% per annum payable monthly in arrears with accrued interest of $375,925 and $262,911 recorded as accrued interest-related party (see Note 4) as of November 30 and February 29, 2020, respectively.

Notes payable and accrued interest-related party, current - $11,960,097 on the condensed balance sheet as of November 30 and $11,333,960 as of February 29, 2020 consists of the Kopple Notes, the Gagerman Note and the Jiangsu Shengfeng Note as set forth below:

Kopple Notes

As of November 30, and February 29, 2020, the principal amount owed to Robert Kopple (former Vice-Chairman of our Board) of $5,607,323 was unchanged. As of November 30, 2020, accrued interest of $5,507,569 was owed to Mr. Kopple for a total balance of $11,114,892. As of February 29, 2020, accrued interest of $4,887,610 was owed to Mr. Kopple for a total balance of $10,494,933.

On August 19, 2013, the Company entered into an agreement with Robert Kopple, a former member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Kopple Notes”) and warrants. The Kopple Notes carried a base interest rate of 9.5%, have a 4-year maturity date and were convertible into shares of common stock at the conversion price of $3.50 per share (conversion feature expired in 2017). The warrants were subsequently exercised. The Company recorded $667,118 as a discount, which has been fully amortized. The Company also entered into a demand note payable with this individual in the amount of $20,000, which bears interest at a rate of 5% per annum.

Gagerman Note

On November 30, 2020, the Gagerman note consisted of $82,000 of unsecured note payable plus accrued interest of $62,628 for a total owed to Melvin Gagerman of $144,628, the Company’s former CEO and CFO, pursuant to a demand note entered into on April 5, 2014. Interest accrues at 10% per annum. On February 29, 2020, the amount owed to Gagerman was $139,026.

Jiangsu Shengfeng Note

On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture, to return $700,000 previously advanced to the Company in September 2018 and recorded as part of customer advance on the balance sheet as of February 28, 2019. Following this agreement which would consists of a non-interest-bearing promissory note and a payment plan pursuant to which the $700,000 would be paid over a 12-month period. Principal loan amount on November 30, 2020 and February 29, 2020 was $700,000, respectively, and is classified as part of notes payable and accrued interest-related party, current on the balance sheets as of November 30, 2020.

Accrued expense-related party – In the second quarter of Fiscal 2021, liabilities with respect to approximately $1,008,000 in accrued payroll and related expenses to former officers of the Company were reversed to other income in the Condensed Statement of Operations for the nine-months ended November 30, 2020 as the related statute of limitation periods were determined to have expired.

NOTE 7 – COMMITMENTS & CONTINGENCIES

Leases

Our facilities consist of approximately 20,000 square feet in Stanton, California and, prior to July 31, 2020, an additional storage facility in Santa Clarita, California. The Stanton facility is used for assembly and testing of AuraGen®/VIPER systems and is rented on a month-to-month basis at $10,000 per month. Prior to July 2020, the Company paid $5,000 per month, also on a month-to-month basis, for the Santa Clarita storage facility. Following the closure of this facility, the Company is currently renting on a month-to-month basis approximately 1,000 square feet of temporary offsite storage space at a monthly cost of approximately $2,500.

Commencing in February 2019 and ending in July 2019, the Company rented approximately 300 square feet of office space in Irvine, California at a cost of $ 2,350 per month on a month-to-month basis.

Following the adoption of Topic 842, Leases, as of the start of Fiscal 2020, the Company determined that there was no impact on its Condensed Financial Statements during the fiscal year ended February 29, 2020, and as of November 30, 2020, it is management’s intention to vacate the existing facilities and consolidate operations at a different location as soon as practical. The standard requires entities to evaluate all lease transactions including leases previously classified as operating leases, and, if required under Topic 842, a right-to-use asset and a corresponding lease liability to be recorded on the balance sheet in the period in which a lease commences.

Contingencies

We are subject to the legal proceedings and claims discussed below as well as certain other legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and evaluates potential losses on such litigation if the amount of the loss is estimable and the loss is probable. However, the outcome of legal proceedings and claims brought against the Company is subject to significant uncertainty. Although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against the Company for amounts in excess of management’s expectations, the Company’s financial statements for that reporting period could be materially adversely affected.

In 2017, the Company’s former COO was awarded approximately $238,000 in accrued salary and related charges by the California labor board. The Company believes that this award does not reflect the amount owed which is significantly lower and is exploring all its options and available remedies and is working toward an offer to settle this matter.

The Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $11.1 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura’s behalf; and approximately $5 million Mr. Kopple claims to be owed for interest, loan fees and late payment charges) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. In July 2017, Mr. Kopple filed suit against the Company as well as against current director Mr. Diaz-Verson and former directors Mr. Breslow and Mr. Howsmon, as well as Mr. Gagerman, our former CEO and a former director, in connection with these allegations. In 2018, the Court dismissed Mr. Diaz-Verson, Mr. Breslow, Mr. Howsmon and Mr. Gagerman from the suit. While the Company believes that it has certain valid defenses in these matters, the Company is currently in settlement discussions with Mr. Kopple. However, to-date, no settlement has been reached in large part because Mr. Kopple continues to demand that as part of any such settlement, he receive unilateral control over significant aspects of the Company’s financial and management functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company’s management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’ duties to shareholders and creditors as a whole.

In May 2018, Shelley Scholnick dba JB Transporters brought suit against the Company claiming ongoing fees in excess of $52,000 owed for the storage of the Company’s property. Notably, in June 2017, the Company had brought suit against J.B. Moving & Delivery, a business operated and controlled by a relative of Scholnick, Jacob Binstok, for damages suffered by the Company as a result of the defendant’s improper storage of the Company’s property and improper refusal to return such property. In 2018, the Company successfully received a judgment against J.B. Moving & Delivery in the amount of approximately $114,000. In April 2020, Aura and Scholnick entered into a Confidential Settlement and Release Agreement wherein (i) the 2018 action initiated by Scholnick against Aura was resolved with no amounts owing by Aura and the complaint and cross-complaint were subsequently dismissed with prejudice; and (ii) the amount owing to Aura pursuant to the judgment against J.B. Moving and Delivery was compromised and resolved through a single lump-sum payment to Aura.

On March 26, 2019, various stockholders of the Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company. On March 27, 2019, those same stockholders delivered a further signed written consent to the Company removing William Anderson and Si Ryong Yu as members of the Company’s Board and electing Robert Lempert and David Mann as directors of the Company. These written consents represented a majority of the outstanding shares of the Company’s common stock as of March 26, 2019 and March 27, 2019, respectively. Because of Aura’s refusal to recognize the legal effectiveness of the consents, on April 8, 2019 the stockholders filed suit in the Court of Chancery of the State of Delaware pursuant to Section 225 of the Delaware General Corporations Law, seeking an order confirming the validity of the consents and declaring that Aura’s Board consists of Ms. Lavut, Mr. Mann, Dr. Lempert, Mr. Douglas and Mr. Diaz-Versón, Jr. On July 8, 2019 the Court of Chancery entered final judgment in favor of the stockholder plaintiffs, confirming that (a) Ronald Buschur, Si Ryong Yu and William Anderson had been validly removed by the holders of a majority of the Company’s outstanding stock acting by written consent (b) Ms. Lavut, Mr. Mann and Dr. Lempert had been validly elected by the holders of a majority of the Company’s outstanding stock acting by written consent, and (c) the Company’s Board of Directors validly consists of Cipora Lavut, David Mann, Robert Lempert, Gary Douglas and Salvador Diaz-Versón, Jr. As a result of prior management’s unsuccessful opposition to this stockholders’ action filed in the Court of Chancery, such stockholders may be potentially entitled to recoup their litigation costs from the Company under Delaware’s corporate benefit doctrine and/or other legal provisions. To-date, no final determination has been made as to the amount of recoupment, if any, to which such stockholders may be entitled.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

This Report contains forward-looking statements within the meaning of the federal securities laws. Statements other than statements of historical fact included in this Report, including the statements under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” regarding future events or prospects are forward-looking statements. The words “approximates,” “believes,” “forecasts,” “expects,” “anticipates,” “estimates,” “intends,” “plans” “would,” “could,” “should,” “seek,” “may,” or other similar expressions in this Report, as well as other statements regarding matters that are not historical fact, constitute forward-looking statements. We caution investors that any forward-looking statements presented in this Report are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results may differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements to anticipate future results or trends.

Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following:

●

Our ability to generate positive cash flow from operations;

●

Our ability to obtain additional financing to fund our operations;

●

The impact of economic, political and market conditions on us and our customers;

●

The impact of unfavorable results of legal proceedings;

●

Our exposure to potential liability arising from possible errors and omissions, breach of fiduciary duty, breach of duty of care, waste of corporate assets and/or similar claims that may be asserted against us;

●

Our ability to compete effectively against competitors offering different technologies;

●

Our business development and operating development;

●

Our expectations of growth in demand for our products; and

●

Other risks described under the heading “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q and those risks discussed in our other filings with the Securities and Exchange Commission, including those risks discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended February 29, 2020, issued on July 13, 2020 (as the same may be updated from time to time in subsequent quarterly reports), which discussion is incorporated herein by this reference.

We do not intend to update or revise any forward-looking statements, whether because of new information, future events or otherwise except to the extent required by law. You should interpret all subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf as being expressly qualified by the cautionary statements in this Report. As a result, you should not place undue reliance on these forward-looking statements.

Overview

Our fiscal year ends on the last day of February. We refer to our fiscal years in this Quarterly Report on Form 10-Q as “Fiscal” and the calendar year in which the fiscal year ends. As such, the current fiscal year ending on February 28, 2021 is designated as Fiscal 2021. The prior fiscal year ended on February 29, 2020 is referred to as Fiscal 2020.

During Fiscal 2017 through 2018, we reduced our engineering, manufacturing, sales, and marketing activities to focus on renegotiating numerous financial obligations and minimizing expenditures while we attempted to raise additional funding and pursue some initial engineering activities.

In Fiscal 2018, we successfully eliminated approximately 68% of our total indebtedness. Specifically, our secured creditors converted approximately $5.73 million of secured debt into approximately 4.1 million shares of our common stock. The converted debt represented approximately 80% of the total secured debt of the Company. The balance of the secured debt (approximately $960,000) is to be paid to the secured creditors in cash if we raise at least $4.0 million in proceeds through new equity offerings in one or a series of related offerings. Additionally, in Fiscal 2018, approximately $12.77 million of unsecured debt was converted into approximately 9.3 million shares of the Company’s common stock and approximately $12.3 million of unsecured debt was forgiven. In total, during Fiscal 2018, we eliminated a total of approximately $30.8 million of debt. In the second quarter of fiscal year 2021 approximately $3.8 million of unpaid salaries, accounts payables and demand notes were extinguished, representing a gain of approximately $3.5 million on the Condensed Statement of Operations for the three and nine-months ended November 30, 2020, as the respective statute of limitation periods were deemed to have expired.

The Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $11.1 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura’s behalf; and approximately $5 million Mr. Kopple claims to be owed for interest, loan fees and late payment charges) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. In July 2017, Mr. Kopple filed suit against the Company as well as against current director Mr. Diaz-Verson and former directors Mr. Breslow and Mr. Howsmon, as well as Mr. Gagerman, our former CEO and a former director, in connection with these allegations. In 2018, the Court sustained demurrers by Mr. Diaz-Verson, Mr. Breslow, Mr. Howsmon and Mr. Gagerman and as a result of these successful demurrers; all four of these defendants have been dismissed from the suit. While the Company believes that it has certain valid defenses in these matters, the Company is currently in settlement discussions with Mr. Kopple. However, to-date, no settlement has been reached in large part because Mr. Kopple continues to demand that as part of any such settlement, he receive unilateral control over significant aspects of the Company’s financial and management functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company’s management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’ duties to shareholders and creditors as a whole.

On February 14, 2018, we effectuated a one-for-seven reverse stock split.

In Fiscal 2019, we began increasing our engineering and manufacturing activities. We utilized contractors for these services in order to minimize our expense while we continued to pursue new sources of financing. In July 2019 under our new management team, we began significantly increasing our sales, engineering, manufacturing and marketing activities.

Our business is based on the exploitation of our patented mobile power solution known as the AuraGen® for commercial and industrial applications and the VIPER for military applications. Our business model consists of two major components: (i) sales and marketing, (ii) design and engineering.

(i) Our sales and marketing approaches are composed of direct sales in North America and the use of agents, distributors. In North America, our primary focus is in (a) mobile exportable power applications, and (c) U.S. Military applications.

(ii) The second component of our business model is focused on the design of new products and engineering support for the sales activities described above. The engineering support consists of the introduction of new features for our AuraGen®/VIPERsolution such as higher power, different voltages, three phase options, shore power systems, higher current solutions as well as interface kits for different platforms. After suspending the majority of our engineering, manufacturing, sales, and marketing activities to focus on renegotiating numerous financial obligations in Fiscal 2018 and 2019, we incurred modest engineering expenses of approximately $70,000 and $169,000 during the three and nine-months ended November 30, 2020, respectively, and approximately $30,000 and $123,000 during the three and nine-months ended November 30, 2019, respectively.

Critical Accounting Policies and Estimates

Our management’s discussion and analysis of our financial conditions and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statements requires management to make estimates and disclosures on the date of the financial statements. In preparing our financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments. The full impact of the COVID-19 pandemic is unknown and cannot be reasonably estimated for these key estimates and assumptions. However, we made appropriate accounting estimates based on the facts and circumstances available as of the reporting date. To the extent that there are differences between these estimates and actual results, our financial statements may be materially affected.

Revenue Recognition

The core principle of ASC 606, Revenue from Contracts with Customers (“ASC 606”), is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In applying ASC 606, all revenue transactions must be evaluated using a five-step approach to determine the amount and timing of revenue to be recognized. The five-step approach requires (1) identifying the contract with the customer, (2) identifying the performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations in the contract and (5) recognizing revenue when performance obligations are satisfied.

Our primary source of revenue is the manufacture and delivery of AuraGen/VIPER sets used primarily in mobile power applications, which represented 100% of our revenues of approximately $7,800 and $61,500 for the three and nine-months ended November 30, 2020, respectively, and $397,000 and $745,000 for the three and nine-months ended November 30, 2019, respectively. Our current principle sales channel is sales to a domestic distributor.

In accordance with ASC 606, we recognize the entirety of the revenue, net of discounts, for our AuraGen/VIPER sets at time of product delivery to the distributor (i.e., point-in-time sale), which also corresponds to the passage of legal title to the customer and the satisfaction of our single performance obligation to the customer. Our payment terms are cash payment due upon delivery and typically includes a 2.5% price discount in accordance with this policy. Our commercial terms and conditions do not include a right of return for reasons other than a defect in performance or quality. We offer 18 months assurance-type warranty covering material and manufacturing defects, which we account for under the guidance of ASC 460, Guarantees. We have a limited history of shipments, and, as such, we have not recorded a warranty liability on our balance sheets as of November 30, 2020 and February 29, 2020, respectively; however, we expect warranty claims to eventually be nil, therefore, we have not delayed the recognition of revenue during Fiscal 2021 and 2020.

Inventory Valuation and Classification

Inventories are valued at the lower of cost (first-in, first-out) or market, on a standard cost basis. We review the components of inventory on a regular basis for excess or obsolete inventory based on estimated future usage and sales. From Fiscal 2015 through 2019 we minimally operated and therefore only produced minimal product. As a result, while we believed that a portion of the inventory had value, we were unable to substantiate demand and fully reserved all inventory in Fiscal 2019. Beginning with Fiscal 2020, production has increased, and fully reserved inventory has been used in current production. We classify all of our inventory as raw material and work-in-process.

Stock-Based Compensation

We account for stock-based compensation under the provisions of FASB ASC 718, “Compensation – Stock Compensation”, which requires the measurement of all share-based payments to employees, including grants of employee stock options, using a fair value-based method and the recording of such expense in the statements of operations.

We account for stock option and warrant grants issued and vesting to non-employees, such as consultants and third parties, in accordance with FASB ASC 718, “Compensation – Stock Compensation”, where appropriate, whereas the fair value of the equity-based compensation is based upon the measurement date as determined at the earlier of either (a) the date at which a performance commitment is reached or (b) at the date at which the necessary performance to earn the equity instruments is complete.

In accordance with established public company accounting practice, we have consistently utilized the Black-Scholes option-pricing model to calculate the fair value of stock options and warrants issued as compensation, primarily to management, employees, and directors. The Black-Scholes option-pricing model is a widely accepted method of valuation that public companies typically utilize to calculate the fair value of options and warrants that they issue in such circumstances. During the nine-month period ended November 30, 2020, our Board of Directors awarded a total of 1,250,000 stock options to the five members of the board, with a five-year term, an exercise price of $0.25 per option, and a vesting period of not less than six-months and one day. Using the Black-Scholes option model, we determined an aggregate fair value of $194,000 of which $20,000 and $194,000 were recorded in the three and nine-months ended November 30, 2020, respectively. No stock-based compensation expense was recorded during Fiscal 2020.

Restatements

We amended our Quarterly Report on Form 10-Q for the period ended November 30, 2019, filed with the SEC on January 14, 2020, solely for the purpose of restating the financial statements (unaudited) and the accompanying notes to the financials due to certain adjustments that were recorded in the fourth quarter ended February 29, 2020; however, to ensure comparability in year-to-year comparisons, these adjustments were restated to the third quarter of Fiscal 2020. The condensed financial statements in his Quarterly Report for the three and nine-months ended November 30, 2020 include the effect of the restatements.

Impact of COVID-19

The COVID-19 global pandemic has negatively affected the global economy, disrupted global supply chains, and created extreme volatility and disruptions to capital and credit markets in the global financial markets. We began to see the impact of COVID-19 during our fourth quarter of Fiscal 2020 with our Chinese joint venture’s manufacturing facilities being required to close and many of our customers suspending their own operations due to the COVID-19 pandemic. As a result, net sales and production levels during the fourth quarter of Fiscal 2020 and the first three quarters of Fiscal 2021 were significantly reduced, thus impacting our results of operations during these quarters.

In response to the COVID-19 pandemic and business disruption, we implemented certain measures to manage costs, preserve liquidity and enhance employee safety. These measures included the following:

●

Enhanced cleaning and disinfection procedures at our facility, promotion of social distancing at our facility and requirements for employees to work from home where possible;

●

Reduction of capital expenditures; and

●

Deferral of discretionary spending.

The extent of the impact of the COVID-19 pandemic on our business, financial results and liquidity will depend largely on future developments, including the duration of the spread of the COVID-19 outbreak within the U.S. and globally, the timing and effectiveness of vaccine development and rollout, and the impact on capital and financial markets and the related impact on our customers, especially in the commercial vehicle markets. These future developments are outside of our control, are highly uncertain and cannot be predicted. If the impact is prolonged, then it can further increase the difficulty of planning for operations and may require us to take further actions as it relates to costs and liquidity. These and other potential impacts of the COVID-19 pandemic have adversely impacted our results for the first three quarters of Fiscal 2021, as well as the full fiscal year 2021, and that impact could be material.

Going Concern

The financial statements contained herein in Item I. Financial Statement have been prepared assuming we will continue as a going concern. During the three and nine-months ended November 30, 2020, we reported net loss of approximately $0.6 million and net profit of $1.5 million, respectively, and had negative cash flows from operating activities of approximately $1.2 million for the nine-month period ended November 30, 2020. The profit in the current year is attributed to recognizing non-operating income associated with the cancellation of certain liabilities due the expiration of the statute of limitations of approximately $3.6 million in the second quarter of Fiscal 2021.

If we are unable to generate operating profits on a sustained basis and are unable to continue to obtain financing for our working capital requirements, we may have to curtail our business sharply or cease business altogether.

Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities. Our continuation as a going concern is dependent upon our ability to generate sufficient cash flow to meet our obligations on a timely basis, to retain our current financing, to obtain additional financing, and ultimately to attain profitability.

Results of Operations

Three months ended November 30, 2020 compared to three months ended November 30, 2019

Net revenue was approximately $7,800 for the three-months ended November 30, 2020 (the “Three-Months FY2021”) compared to approximately $397,000 for the three-months ended November 30, 2019 (the “Three-Months FY2020”). During the current quarter of 2021, we delivered 1 generator unit as compared to 64 units delivered in the same quarter in the prior year. Revenue year-on-year has been negatively impacted by the COVID-19 pandemic. We cannot project with confidence the timing or amount of revenue that we can expect until the pandemic is under control following a successful rollout of the vaccine programs now underway.

Cost of goods sold was approximately $5,300 in the Three-Months FY2021 compared to approximately $116,000 in the Three-Months FY2020 resulting in a gross profit of $2,500, or a gross margin of 32%, and a $281,000 gross profit in the Three-Months FY2020 and a gross margin of 71%. Gross profit and related gross margin for the Three-Months FY2021 shipments were largely influenced by the low volume of shipments in the quarter which reduced our ability to fully absorb fixed operating costs. The gross margin of 71% in the Three-Months FY2020 was achieved by taking advantage of inventory on-hand, previously fully reserved due to lack of estimable demand, to offset the unit cost of 64 units sold in the current quarter. We do not expect gross margins above 70% to occur regularly for shipments of generator units in future quarters as the availability of usable parts from fully reserved inventory will decline over time.

Engineering, research and development expenses were approximately $70,000 in the Three-Months FY2021, compared to approximately $31,000 in the Three-Months FY2020, or an increase of 130%.

Selling, general and administrative (“SG&A”) expense declined by approximately $149,000 (37%) to approximately $268,000 in the Three-Months FY2021 from approximately $407,000 in the Three-Months FY2020. During Three-Months FY2021, we recorded increased expense for (i) $20,000 of stock-based compensation expense related to the grant of 1,250,000 options to our five board members, (ii) $24,000 in one-time costs to physically close our offsite storage facility in Santa Clarita, CA and consolidate usable inventory into temporary storage facilities (iii) incurred additional salaries and consulting costs of approximately $38,000; fully offset by reductions of (i) $32,000 for building rent due to consolidation of storage facilities, (ii) reduced legal and accounting fees of $142,000, and (iii) reduced travel expenses of $57,000 due to Covid-19 restrictions.

Interest expense in the Three-Months FY2021 decreased approximately $16,000 or 6%, to approximately $268,000 from approximately $284,000 in the Three-Months FY2020 due to $34,000 of notes payable settled for common stock in November 2019 and the extinguishment of debt of $872,000 in the second quarter of Fiscal 2021.

Other income in the Three-Months FY2021 was approximately $4,000, as compared to nil in the same period of Fiscal 2020. Other loss from settlements of approximately $333,000 in the Three-Months FY2020 was attributed to the debt settlement in Fiscal 2020 of amounts due to our president of approximately $330,000 through the issuance of 1,030,385 common shares.

Net loss for the Three-Months FY2021 improved by approximately $184,000, to approximately $590,000 from a loss of $774,000 in the Three-Months FY2020 adversely attributed to reduced gross profit of $279,000 due to reduced sales of generator units fully offset by (i) less interest expense of $16,000, (ii) reduced engineering, sales and general administrative expenses of $109,000, and (iii) the non-recurring loss of 329,000 related to shares issued for debt settlement in Fiscal 2020.

Nine months ended November 30, 2020 compared to nine months ended November 30, 2019

Net revenue was approximately $62,000 for the nine-months ended November 30, 2020 (the “Nine-Months FY2021”) compared to $745,000 for the nine-months ended November 30, 2019 (the “Nine-Months FY2020”). During Nine-Months FY2021, we delivered 10 generator units as compared to 116 units delivered in Nine-Months FY2020. Revenue year-on-year has been negatively impacted by the COVID-19 pandemic. We cannot project with confidence the timing or amount of revenue that we can expect until the pandemic is under control or until an effective vaccine becomes widely available.

Cost of goods sold was approximately $47,000 in the Nine-Months FY2021 compared to approximately $148,000 in the Nine-Months FY2020 resulting in a gross profit of $15,000, or a gross margin of 24%, and a $597,000 gross profit in the Nine-Months FY2020 and a gross margin of 80%. Gross profit and related gross margin for the Nine-Months FY2021 shipments were largely influenced by the low volume of shipments in the period which reduced our ability to fully absorb fixed operating costs. The gross margin of 80% in the Nine-Months FY2020 was achieved by taking advantage of inventory on-hand, previously fully reserved due to lack of estimable demand, to offset the unit cost of 116 units sold year-to-date. We do not expect gross margins above 80% to occur regularly for shipments of generator units in future periods as the availability of usable parts from fully reserved inventory will decline.

Engineering, research and development expenses were approximately $169,000 in the Nine-Months FY2021, compared to approximately $123,000 in the Nine-Months FY2020, or an increase of 37%

Selling, general and administrative (“SG&A”) expense increased approximately $119,000 (13%) to approximately $1,035,000 in the Nine-Months FY2021 from approximately $916,000 in the Nine-Months FY2020. During Nine-Months FY2021, we recorded increased expenses of (i) $194,000 of stock-based compensation expense related to the grant of 1,250,000 options to our five board members, (ii) incurred approximately $85,000 in one-time costs to physically close our offsite storage facility in Santa Clarita, CA and consolidate usable inventory into temporary storage facilities (iii) salaries and consulting costs of approximately $52,000; offset partially by reduced expenses for (i) professional fees of $78,000, (ii) rent of $31,000, (iii) travel and entertainment of $82,000 due to restrictions under Covid-19 and (iv) other expenses of $21,000.

Net interest expense in the Nine-Months FY2021 decreased approximately $1,000 or 1%, to approximately $886,000 from approximately $885,000 in the Nine-Months FY2020.

Gain on other settlements was $46,000 in the Nine-Months FY2021 as compared to $0 in the same period of Fiscal 2020 due primarily to the settlement of a legal issue. Loss on other settlements of $333,000 in the Nine-Months FY2020 was attributed to a debt settlement with our president of approximately $330,000 in exchange for 1,030,385 shares of common stock. Other income and gain on extinguishment of debt totals approximately $3.6 million in the Nine-Months FY2021, as compared to nil in the same period of Fiscal 2020. This amount was attributed to the cancellation of approximately $2.4 million in accrued payroll and related expenses, $0.4 million in accounts payable, and three demand notes of approximately $0.8 million consisting of interest and principal, all of which represent liabilities with respect to which the applicable statute of limitation periods have been deemed to have expired.

Net income for the Nine-Months FY2021 improved by approximately $3.2 million, to net income of approximately $1.5 million from a loss of $1.7 million in the Nine-Months FY2020 adversely attributed to (i) reduced gross profit of $0.6 million due to reduced sales of generator units and (ii) increased engineering, sales and general administrative expenses of $0.2 million; fully offset by (i) other income and gain on extinguishment of debt of $3.6 million related to the cancellation of liabilities due to expiration of statute of limitations and (ii) the non-recurring loss of $0.3 million related to shares issued for debt settlement in Fiscal 2020 and (iii) other income of $0.1 million.

Liquidity and Capital Resources

Net cash used in operations for the nine-months ended November 30, 2020, was approximately $1,246,000, an increase of $755,000 from the comparable period in the prior fiscal year. Net cash provided by financing activities during the nine-months ended November 30, 2020, was approximately $1,379,000 consisting of (i) cash proceeds from issuance of common stock of $1,220,000, (ii) combined proceeds of $224,000 related to the U.S. federal Paycheck Protection Program (“PPP”) loan program related to COVID-19 and the U.S. Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL”) loan program, and partially offset by (iii) $65,000 principal payments on a note payable; compared to cash provided by financing of $255,000 in the same period of Fiscal 2020 consisting of cash proceeds from the issuance common shares of $295,000, partially offset by $40,000 principal payments on a note payable. The cash flow generated from our operations to date has not been sufficient to fund our working capital needs, and we cannot predict when operating cash flow will be sufficient to fund working capital needs.

There was a $9,000 acquisition of property and equipment during the three and nine-months ended November 30, 2020, respectively. During Fiscal 2020, there were no acquisitions of property and equipment.

The total of accrued expenses and accrued expenses-related party as of November 30, 2020 decreased by approximately $2.3 million to $686,000 from approximately $2,954,000 as of February 29, 2020 due to the cancellation of the unpaid salaries of $2.3 million. During the same nine-month period in Fiscal 2021, accrued interest on all notes payable due to related parties and non-related parties increased by approximately $848,000 for recurring interest costs offset by approximately $386,000 of debt extinguishment related to the three demand notes because of statute of limitations expiration.

The Company had a deficit of $20.0 million in shareholders’ equity as of November 30, 2020, compared to $23.3 million as of February 29, 2020 with the net positive change of $3.3 million attributed to (i) net profit year-to-date of approximately $1.6 million (ii) the net issuance of approximately 8.1 million shares valued at approximately $1.5 million for cash and (ii) the granting to board members 1,250,000 options in March 2020 with an aggregate fair value of approximately $0.2 million, all of which approximately was recognized as expense during the nine-months ended November 30, 2020.

On April 23, 2020, we obtained a PPP loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, loan payments are deferred for 10 months following the last day of the covered period or June 23, 2020, balance is payable in 24 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company intends to use the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. While we intend to apply for the forgiveness of the PPP Loan, there is no assurance that we will obtain forgiveness of the PPP Loan in whole or in part.

On July 1, 2020, we obtained an EIDL loan in the amount of $149,900 administered by the SBA. As required under this program, the proceeds of the loan are to be used for payments of ordinary working capital needs negatively impacted by the COVID-19 pandemic. Interest accrues from the date of the loan of July 1, 2020 at a rate of 3.75% per annum, a loan term of 30 years, no prepayment penalties or fees, and there is a one-year deferral period during which interest accrues but no payments are required to be made. Following the deferral period for a period of 29 years, an estimated monthly payment of $734 is required to fully amortize the principal and accrued interest over the term of the loan. The Company pledged the assets of the Company as collateral for the loan.

In the past, in order to generate liquidity, we have relied upon external sources of financing, principally equity financing and private indebtedness. We have no bank line of credit and require additional debt or equity financing to fund ongoing operations. The issuance of additional shares of equity in connection with any such financing could dilute the interests of our existing stockholders, and such dilution could be substantial. If we cannot raise needed funds, we would also be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we are not required to provide disclosure under this Item 3.

ITEM 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the specified time periods. For the last 3 Fiscal years, these control and procedures broke down due to insufficient capital to maintain such controls and procedures. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to its management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period covered by this report, the Company’s management evaluated, with the participation of the Company’s Principal Executive Officer and Chief Financial Officer, the effectiveness of the Company’s disclosure controls and procedures. Based on the evaluation, the Company’s Principal Executive Officer and Chief Financial Officer concluded that these controls and procedures were effective as of the end of the period covered by this report in ensuring that information requiring disclosure is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms. The Company continues to remediate the findings contained in our Annual Report on Form 10-K, for the Fiscal year ended February 29, 2020, issued on July 13, 2020.

Changes in Internal Control over Financial Reporting

There have been no other changes in our internal control over financial reporting during our fiscal quarter ended November 30, 2020, not previously identified in our Annual Report on Form 10-K, for the Fiscal year ended February 29, 2020 and issued on July 13, 2020 which have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. Legal Proceedings

The Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $10.9 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura’s behalf; and approximately $5.3 million Mr. Kopple claims to be owed for interest, loan fees and late payment charges) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. In July 2017, Mr. Kopple filed suit against the Company as well as against current director Mr. Diaz-Verson and former directors Mr. Breslow and Mr. Howsmon, as well as Mr. Gagerman, our former CEO and a former director, in connection with these allegations. In 2018, the Court sustained demurrers by Mr. Diaz-Verson, Mr. Breslow, Mr. Howsmon and Mr. Gagerman and as a result of these successful demurrers; all four of these defendants have been dismissed from the suit. While the Company believes that it has certain valid defenses in these matters, the Company is currently in settlement discussions with Mr. Kopple. However, to-date, no settlement has been reached in large part because Mr. Kopple continues to demand that as part of any such settlement, he receive unilateral control over significant aspects of the Company’s financial and management functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company’s management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’ duties to shareholders and creditors as a whole.

ITEM 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Item 1A, “Risk Factors,” of the Company’s Fiscal 2020 Annual Report on Form 10-K issued on July 13, 2020.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the nine-months ended November 30, 2020, we issued 8,117,638 shares of common stock for cash proceeds of $1,220,000.

ITEM 3. Defaults Upon Senior Securities.

As of the date of this filing, Robert Kopple, our former Vice Chairman of the Board, is the only significant unsecured note holder that has not executed formal agreements regarding the restructure of his debt. Mr. Kopple claims that he and his affiliates are owed approximately $10.9 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura’s behalf; and approximately $5.3 million Mr. Kopple claims to be owed for interest, loan fees and late payment fees) on terms significantly preferable to other similarly situated unsecured creditors as well as warrants to purchase approximately 3.3 million shares of our common stock. We dispute Mr. Kopple’s claims and we are currently in a legal dispute regarding these claims. See “Item 1. Legal Proceedings” included elsewhere in this Quarterly Report on Form 10-Q for information regarding the dispute with Mr. Kopple regarding these transactions as well as “Note 3 – Notes Payable” and “Note 5 – Related Parties Transactions” to the Company’s condensed financial statements, “Liquidity and Capital Resources” in “Item 2 and Management’s Discussion and Analysis of Financial Condition and Results of Operations” elsewhere in this quarterly report on Form 10-Q for additional information regarding amounts that may be owed under the Company’s notes payable and the recent restructuring of certain Company debt. Mr. Kopple has not accepted our numerous offers to settle this debt and continues to demand that as part of any such resolution, he receive unilateral control over significant aspects of the Company’s financial and management functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company’s management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’ duties to shareholders and creditors as a whole.

In June 2014, we entered into a Financing Letter of Agreement (the “June 2014 Agreement”) with two affiliate entities of Mr. Kopple, KF Business Ventures and the Kopple Family Partnership (the “Additional Kopple Parties”), pursuant to which the Additional Kopple Parties loaned us an additional $1,000,000 (the “June 2014 Loan”). In connection with the June 2014 Loan, Mr. Kopple also added $202,205 in penalties and accrued interest, credited us with $200,000 for amounts previously repaid by us and several earlier advances into a single new note (the “June 2014 Kopple Note”) in the principal amount of $2,715,2067 and bearing simple interest at a rate of 10% per annum.

Pursuant to the June 2014 Agreement, the Kopple Parties also placed various restrictions on our ability to raise additional capital, hire qualified personnel and pay certain expenses without his prior approval for so long as the principal amount of his note remained outstanding. The June 2014 Kopple Note also required us to issue Mr. Kopple a stock purchase warrant (the “June 2014 Kopple Warrant”) to purchase approximately 771,000 shares of our common stock at an exercise price of $0.70 per share, to be exercisable for seven years. Additionally, if we borrowed funds, issued capital stock or rights to acquire or convert into capital stock, or granted rights in respect to territories to any person for cash consideration of more than $5 million in the aggregate after the date of the June 2014 Kopple Note, we would be required to pay the entire amount of such cash consideration in excess of $5 million as a mandatory prepayment of the June 2014 Kopple Note. Additionally, Mr. Kopple required a default provision providing that in the event that the entire outstanding balance of the June 2014 Kopple Note was not paid in full prior to October 1, 2014, then for each consecutive calendar month during the period beginning October 1, 2014 and ending March 31, 2015, we would issue to Mr. Kopple additional stock purchase warrants, each to purchase 416,458 shares of our common stock, up to a maximum aggregate of approximately 2.5 million shares of our common stock, at $0.70 per share (the “Kopple Penalty Warrants”), the Kopple Penalty Warranties to be exercisable for seven years from the time of their respective issuances. In addition to the Kopple Penalty Warrants, the default provision under the June 2014 Kopple Note provides for a 5% late charge on the total amount due plus 15% per year interest. We have not repaid the Kopple Parties in full for the amounts loaned to us. Additionally, we have not issued any of the Kopple Penalty Warrants and management believes that Mr. Kopple is not entitled to receive them. We have also cancelled the June 2014 Kopple Warrant.

We consider the transactions described above with Mr. Kopple to be related party transactions.

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information.

None.

ITEM 6. Exhibits

31.1		Certification pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.

31.2		Certification pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.

32.1		Certification of Principal Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. § 1350, as Adopted Pursuant to § 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Schema Document

101.CAL		XBRL Calculation Linkbase Document

101.DEF		XBRL Definition Linkbase

101.LAB		XBRL Label Linkbase Document

101.PRE		XBRL Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: January 19, 2021	AURA SYSTEMS, INC.
	(Registrant)

	By:	/s/ Cipora Lavut
		Cipora Lavut
		President

EX-31.1 2 f10q1120ex31-1_aurasys.htm CERTIFICATION

Exhibit 31.1

CERTIFICATION

I, Cipora Lavut, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Aura Systems, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: January 19, 2021

By:	/s/ Cipora Lavut
	Cipora Lavut
	President

EX-31.2 3 f10q1120ex31-2_aurasys.htm CERTIFICATION

Exhibit 31.2

CERTIFICATION

I, David Mann, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Aura Systems, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: January 19, 2021

By:	/s/ David Mann
	David Mann
	Chief Financial Officer

EX-32.1 4 f10q1120ex32-1_aurasys.htm CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

Exhibit 32.1

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Cipora lavut, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Aura Systems, Inc. on Form 10-Q for the period ended November 30, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Aura Systems, Inc. at the dates and for the periods indicated.

Date: January 19, 2021

By:	/s/ Cipora Lavut
	Cipora Lavut
	President

I, David Mann, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Aura Systems, Inc. on Form 10-Q for the period ended November 30, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Aura Systems, Inc. at the dates and for the periods indicated.

Date: January 19, 2021

By:	/s/ David Mann
	David Mann
	Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Aura Systems, Inc. and will be retained by Aura Systems, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 5 ausi-20201130.xml XBRL INSTANCE FILE 0000826253 2020-03-01 2020-11-30 0000826253 2020-11-30 0000826253 2020-02-29 0000826253 2020-09-01 2020-11-30 0000826253 2019-09-01 2019-11-30 0000826253 2019-03-01 2019-11-30 0000826253 2019-02-28 0000826253 2019-11-30 0000826253 us-gaap:CommonStockMember 2019-02-28 0000826253 us-gaap:AdditionalPaidInCapitalMember 2019-02-28 0000826253 us-gaap:RetainedEarningsMember 2019-02-28 0000826253 us-gaap:CommonStockMember 2019-03-01 2019-05-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2019-03-01 2019-05-31 0000826253 2019-03-01 2019-05-31 0000826253 us-gaap:RetainedEarningsMember 2019-03-01 2019-05-31 0000826253 us-gaap:CommonStockMember 2019-05-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2019-05-31 0000826253 us-gaap:RetainedEarningsMember 2019-05-31 0000826253 2019-05-31 0000826253 us-gaap:CommonStockMember 2019-06-01 2019-08-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2019-06-01 2019-08-31 0000826253 us-gaap:RetainedEarningsMember 2019-06-01 2019-08-31 0000826253 2019-06-01 2019-08-31 0000826253 us-gaap:CommonStockMember 2019-08-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2019-08-31 0000826253 us-gaap:RetainedEarningsMember 2019-08-31 0000826253 2019-08-31 0000826253 us-gaap:CommonStockMember 2019-09-01 2019-11-30 0000826253 us-gaap:AdditionalPaidInCapitalMember 2019-09-01 2019-11-30 0000826253 us-gaap:RetainedEarningsMember 2019-09-01 2019-11-30 0000826253 us-gaap:CommonStockMember 2019-11-30 0000826253 us-gaap:AdditionalPaidInCapitalMember 2019-11-30 0000826253 us-gaap:RetainedEarningsMember 2019-11-30 0000826253 us-gaap:CommonStockMember 2020-02-29 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-02-29 0000826253 us-gaap:RetainedEarningsMember 2020-02-29 0000826253 us-gaap:CommonStockMember 2020-03-01 2020-05-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-03-01 2020-05-31 0000826253 us-gaap:RetainedEarningsMember 2020-03-01 2020-05-31 0000826253 2020-03-01 2020-05-31 0000826253 us-gaap:CommonStockMember 2020-05-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-05-31 0000826253 us-gaap:RetainedEarningsMember 2020-05-31 0000826253 2020-05-31 0000826253 us-gaap:CommonStockMember 2020-06-01 2020-08-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-06-01 2020-08-31 0000826253 us-gaap:RetainedEarningsMember 2020-06-01 2020-08-31 0000826253 2020-06-01 2020-08-31 0000826253 us-gaap:CommonStockMember 2020-08-31 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0000826253 us-gaap:RetainedEarningsMember 2020-08-31 0000826253 2020-08-31 0000826253 us-gaap:CommonStockMember 2020-09-01 2020-11-30 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-09-01 2020-11-30 0000826253 us-gaap:RetainedEarningsMember 2020-09-01 2020-11-30 0000826253 us-gaap:CommonStockMember 2020-11-30 0000826253 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0000826253 us-gaap:RetainedEarningsMember 2020-11-30 0000826253 ausi:DemandPromissoryNotesPayableMember 2020-11-30 0000826253 ausi:DemandPromissoryNotesPayableMember ausi:MrZeitlinMember 2020-03-01 2020-11-30 0000826253 ausi:DemandPromissoryNotesPayableMember 2020-03-01 2020-11-30 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2013-06-01 2013-06-20 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2013-06-20 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2018-03-01 2019-02-28 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2018-09-01 2018-09-30 0000826253 ausi:FormerChiefExecutiveOfficerMember ausi:SecuredCreditorsTwoMember 2020-03-01 2020-11-30 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2020-11-30 0000826253 ausi:AbdouAndAbdouMember us-gaap:ConvertibleNotesPayableMember 2019-03-01 2020-02-29 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2013-05-01 2013-05-07 0000826253 ausi:KenmontCapitalPartnersMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2013-05-01 2013-05-07 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2020-11-30 0000826253 ausi:GuentherMember ausi:RefinancingAgreementsMember us-gaap:ConvertibleNotesPayableMember 2013-05-01 2013-05-07 0000826253 ausi:GuentherMember ausi:RefinancingAgreementsMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 ausi:GuentherMember ausi:RefinancingAgreementsMember us-gaap:ConvertibleNotesPayableMember 2013-05-07 0000826253 ausi:GuentherMember ausi:RefinancingAgreementsMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2020-11-30 0000826253 ausi:DresnerLempertMember us-gaap:ConvertibleNotesPayableMember 2013-06-01 2013-06-20 0000826253 ausi:DresnerLempertMember us-gaap:ConvertibleNotesPayableMember 2013-06-20 0000826253 ausi:DresnerLempertMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2020-11-30 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2012-08-01 2012-08-10 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2012-08-10 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleDebtMember 2012-08-01 2012-08-10 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2018-01-11 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2020-03-01 2020-11-30 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2012-10-01 2012-10-02 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2012-10-02 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember ausi:ConvertibleDebtOneMember 2018-01-11 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember ausi:ConvertibleDebtOneMember 2020-03-01 2020-11-30 0000826253 us-gaap:ConvertibleDebtMember 2017-01-01 2017-01-30 0000826253 2020-04-01 2020-04-23 0000826253 2020-06-25 2020-07-01 0000826253 ausi:DemandPromissoryNotesPayableMember 2020-02-29 0000826253 ausi:LpdInvestmentsMember us-gaap:ConvertibleNotesPayableMember 2019-03-01 2020-02-29 0000826253 2019-03-01 2020-02-29 0000826253 ausi:DresnerLempertMember us-gaap:ConvertibleNotesPayableMember 2019-03-01 2020-02-29 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember us-gaap:ConvertibleNotesPayableMember 2019-03-01 2020-02-29 0000826253 ausi:DalrympleMember us-gaap:UnsecuredDebtMember ausi:ConvertibleDebtOneMember 2019-03-01 2020-02-29 0000826253 ausi:MessrsAbdouNotesPayableMember 2020-11-30 0000826253 ausi:MessrsAbdouNotesPayableMember 2020-02-29 0000826253 ausi:USPayrollProtectionPlanLoanProgramMember 2020-11-30 0000826253 ausi:USSmallBusinessAdministrationEconomicInjuryDisasterLoanMember 2020-11-30 0000826253 ausi:ConvertibleMember 2020-11-30 0000826253 ausi:ConvertibleMember 2020-02-29 0000826253 ausi:ConvertibleOneMember 2020-11-30 0000826253 ausi:ConvertibleOneMember 2020-02-29 0000826253 ausi:ConvertibleTwoMember 2020-11-30 0000826253 ausi:ConvertibleTwoMember 2020-02-29 0000826253 ausi:ConvertibleThreeMember 2020-11-30 0000826253 ausi:ConvertibleThreeMember 2020-02-29 0000826253 ausi:NotesPayableMember 2020-11-30 0000826253 ausi:NotesPayableMember 2020-02-29 0000826253 ausi:KoppleNotesPayableRelatedPartyMember 2020-11-30 0000826253 ausi:KoppleNotesPayableRelatedPartyMember 2020-02-29 0000826253 ausi:MelGagermanNotesPayableMember 2020-11-30 0000826253 ausi:MelGagermanNotesPayableMember 2020-02-29 0000826253 ausi:JiangsuShengfengMember 2020-11-30 0000826253 ausi:JiangsuShengfengMember 2020-02-29 0000826253 ausi:ConvertibleMember 2020-03-01 2020-11-30 0000826253 ausi:ConvertibleOneMember 2020-03-01 2020-11-30 0000826253 ausi:ConvertibleTwoMember 2020-03-01 2020-11-30 0000826253 ausi:ConvertibleThreeMember 2020-03-01 2020-11-30 0000826253 us-gaap:CommonStockMember 2020-03-01 2020-11-30 0000826253 us-gaap:CommonStockMember 2019-03-01 2019-11-30 0000826253 2019-03-01 2019-08-31 0000826253 2020-03-01 2020-08-31 0000826253 us-gaap:InvestorMember 2019-03-01 2019-11-30 0000826253 ausi:TwoThousandSixPalnMember 2020-03-01 2020-11-30 0000826253 ausi:TwoThousandElevenPalnMember 2020-03-01 2020-11-30 0000826253 ausi:TwoThousandSixPalnMember 2020-02-29 0000826253 ausi:TwoThousandSixPalnMember 2020-03-01 2020-11-30 0000826253 ausi:TwoThousandSixPalnMember 2020-11-30 0000826253 srt:MinimumMember ausi:StockOptionsPlansExercisePriceRangeMember 2020-03-01 2020-11-30 0000826253 srt:MaximumMember ausi:StockOptionsPlansExercisePriceRangeMember 2020-03-01 2020-11-30 0000826253 ausi:StockOptionsPlansExercisePriceRangeMember 2020-11-30 0000826253 ausi:StockOptionsPlansExercisePriceRangeMember 2020-03-01 2020-11-30 0000826253 us-gaap:WarrantMember 2020-02-29 0000826253 us-gaap:WarrantMember 2020-03-01 2020-11-30 0000826253 us-gaap:WarrantMember 2020-11-30 0000826253 ausi:RangeOfExercisePricesMember us-gaap:WarrantMember 2020-11-30 0000826253 ausi:RangeOfExercisePricesMember us-gaap:WarrantMember 2020-03-01 2020-11-30 0000826253 srt:DirectorMember 2017-01-24 0000826253 srt:DirectorMember us-gaap:ConvertibleDebtMember 2017-01-01 2017-01-24 0000826253 srt:DirectorMember 2018-02-01 2018-02-14 0000826253 us-gaap:CommonStockMember 2018-02-01 2018-02-14 0000826253 srt:DirectorMember 2020-11-30 0000826253 srt:DirectorMember 2020-03-01 2020-11-30 0000826253 srt:DirectorMember 2019-03-01 2020-02-29 0000826253 srt:BoardOfDirectorsChairmanMember 2020-11-30 0000826253 srt:BoardOfDirectorsChairmanMember 2020-02-29 0000826253 srt:BoardOfDirectorsChairmanMember 2020-03-01 2020-11-30 0000826253 srt:BoardOfDirectorsChairmanMember 2019-03-01 2020-02-29 0000826253 srt:ChiefExecutiveOfficerMember us-gaap:UnsecuredDebtMember 2020-11-30 0000826253 srt:ChiefExecutiveOfficerMember us-gaap:UnsecuredDebtMember 2020-03-01 2020-11-30 0000826253 srt:ChiefExecutiveOfficerMember us-gaap:UnsecuredDebtMember 2020-02-29 0000826253 ausi:JiangsuShengfengMember 2019-03-01 2019-11-30 0000826253 ausi:JiangsuShengfengMember 2020-11-30 0000826253 ausi:JiangsuShengfengMember 2020-02-29 0000826253 2020-07-31 0000826253 ausi:StantonFacilityMember 2020-03-01 2020-11-30 0000826253 ausi:StorageFacilityMember 2020-03-01 2020-11-30 0000826253 ausi:OffsiteStorageSpaceMember 2020-03-01 2020-11-30 0000826253 ausi:OfficeSpaceMember 2020-11-30 0000826253 ausi:OfficeSpaceMember 2020-03-01 2020-11-30 0000826253 us-gaap:CaliforniaFranchiseTaxBoardMember 2017-12-31 0000826253 srt:DirectorMember 2020-03-01 2020-11-30 0000826253 2018-05-01 2018-05-31 0000826253 2018-12-01 2018-12-31 0000826253 2019-03-01 2019-03-26 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:sqm false --02-28 Q3 2021 2020-11-30 10-Q 0000826253 Yes false 000-17249 Non-accelerated Filer DE No AURA SYSTEMS INC false true 64518512

143693

19807

105166

90037

35787

1487

284645

111330

8624

293269

111330

1873745

2537061

730588

1946290

440331

1008328 375925 262911 217395 498698

189116

983717

11960097

11333960

15787197

19011296

3000000

197725

1402971 1402971

20387894

23414267

6450

5639

445097390

443417452

-465198465

-466726027

-20094625

-23302937

293269

111330

0.0001

150000000

64518512

56400874

64518512

56400874

7829

396775

61462

744850

5320

115655

46718

147752

2510

281119

14743

597097

70217

30472

169318

123024

258528

407652

1034836

915934

328744

438124

1204154

1038958

-326235

-157005

-1189411

-441861

268017

283928

884751

885731

-4391

-107

-2683805

-107

-871887

-32 333512 -46032 333512

-589829

-774337

1527562

-1660997

-589829

-774337

1527562

-1660997

-0.01

0.03

-0.03

62664666

55296222

59803498

54012831

-0.01

0.03

-0.03

62664666

55296222

61183610

54012831

1527562

-1660996

-329723

297

193750

3585639

15129

53163

34300

-8357

847987

855534

-181026

29966

-1246498

-490579

8921

1220000

295245

65000

40000

224305

1379305

255245

123886

-235334

358209

122875

2500

267000 13159 20501

53714145

5371

442519092

-464119162

-21594699

156250

49985

50000

-675321

53870395

5386

442569077

-464794483

-22220020

501765

100302

100353

1030385 103 329620 329723

-211339

55402545

5540

442998999

-465005822

-22001283

725000

144928

145001

-1065051

107

168380

16 33642 33658

-774337

55230874

5522

443177569

-465780159

-22597068

56400874

5641

443417449

-466726027

1358333

135

234865

235000

77599 77599

-606001

57759207

5776

443729913

-467332029

-23596340

3866665

387

579613

580000

192641 19 266981 267000 96476 96476

2723392

61818513

6182

444672983

-464608637

-19929472

2699999

270

404730

405000

19674 19674

-589829

64518512

6452

445097387

-465198466

NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations Aura Systems, Inc., (“Aura”, “We” or the “Company”) a Delaware corporation, was founded to engage in the development, commercialization, and sale of products, systems, and components, using its patented and proprietary electromagnetic technology. Aura develops and sells AuraGen® axial flux mobile induction power systems to the industrial, commercial, and defense mobile power generation markets. Basis of Presentation  In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. However, the results of operations included in such financial statements may not necessary be indicative of annual results. The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended February 29, 2020 (“Fiscal 2020”) filed with the Securities and Exchange Commission (“SEC”) on July 13, 2020 (“2020 Form 10-K.”). The Company amended its Quarterly Report on Form 10-Q for the period ended November 30, 2019, filed with the SEC on January 14, 2020, solely for the purpose of restating the financial statements (unaudited) and the accompanying notes to the financials due to certain adjustments that were recorded in the fourth quarter ended February 29, 2020; however, to ensure comparability in year-to-year comparisons, these adjustments were restated to the third quarter of Fiscal 2020. The condensed financial statements in his Quarterly Report for the three and nine-months ended November 30, 2020 include the effect of the restatements. Our fiscal year ends on the last day of February. Accordingly, the current fiscal year is ending on February 28, 2021; we refer to the current fiscal as (“Fiscal 2021”). The prior fiscal year is Fiscal 2020. Significant Accounting Policies For a detailed discussion about the Company’s significant accounting policies, refer to Note 2 — “Summary of Significant Accounting Policies,” in our financial statements included in Company’s 2020 Form 10-K. During the three and nine-months ended November 30, 2020, the Company recognized aggregate gains of approximately $2.7 million in connection with the cancellation of certain accounts payable balances and accrued payroll related to unpaid wages and salaries and approximately $0.9 million in connection with demand promissory notes with three persons for which the respective statute of limitations periods have expired. Earnings Per Share The following table sets forth the basic and dilutive earnings per share for the nine-months ended November 30, 2020. The dilutive earning per share includes only the dilutive incremental effect of additional shares issued on an “as if converted basis” in relation to the convertible notes payable principal amounts outstanding as of November 30, 2020 (see Notes 3 and 6). The three-months ended November 30, 2020 was not included in the following table as the effect is anti-dilutive. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine-Months Ended November 30, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Income</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Per-share</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Numerator)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">(denominator)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif">Basic EPS</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Income available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1,527,562</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">59,803,498</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">0.03</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Effect of Dilutive Securities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Convertible notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17,155</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,380,112</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.01</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Dilutive EPS</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">Income available to common stockholders plus assumed conversions</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,544,716</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">61,183,610</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.03</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table> Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Reclassifications Certain prior period amounts have been reclassified to conform to the current year presentation. Recently Issued Accounting Pronouncements In June 2016, the FASB issued Accounting Standards Update 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instrument. Subsequent to the issuance of ASU 2016-13, the FASB clarified the guidance through several ASUs. The collective new guidance (ASC 326) generally requires entities to use a current expected credit loss model, which is a new impairment model based on expected losses rather than incurred losses. Under this model, an entity would recognize an impairment allowance equal to its current estimate of all contractual cash flows that the entity does not expect to collect. The entity’s estimate would consider relevant information about past events, current conditions, and reasonable and supportable forecasts. ASC 326 is effective for annual and interim fiscal reporting periods beginning after December 15, 2022, with early adoption permitted for annual reporting periods beginning after December 15, 2018. The Company is continuing to evaluate the expected impact of this ASC 326 but does not expect it to have a material impact on its financial statements upon adoption.

Nature of Operations Aura Systems, Inc., (“Aura”, “We” or the “Company”) a Delaware corporation, was founded to engage in the development, commercialization, and sale of products, systems, and components, using its patented and proprietary electromagnetic technology. Aura develops and sells AuraGen® axial flux mobile induction power systems to the industrial, commercial, and defense mobile power generation markets.

Basis of Presentation  In the opinion of management, the unaudited interim condensed financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. However, the results of operations included in such financial statements may not necessary be indicative of annual results. The Company uses the same accounting policies in preparing quarterly and annual financial statements. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended February 29, 2020 (“Fiscal 2020”) filed with the Securities and Exchange Commission (“SEC”) on July 13, 2020 (“2020 Form 10-K.”). The Company amended its Quarterly Report on Form 10-Q for the period ended November 30, 2019, filed with the SEC on January 14, 2020, solely for the purpose of restating the financial statements (unaudited) and the accompanying notes to the financials due to certain adjustments that were recorded in the fourth quarter ended February 29, 2020; however, to ensure comparability in year-to-year comparisons, these adjustments were restated to the third quarter of Fiscal 2020. The condensed financial statements in his Quarterly Report for the three and nine-months ended November 30, 2020 include the effect of the restatements. Our fiscal year ends on the last day of February. Accordingly, the current fiscal year is ending on February 28, 2021; we refer to the current fiscal as (“Fiscal 2021”). The prior fiscal year is Fiscal 2020.

Significant Accounting Policies For a detailed discussion about the Company’s significant accounting policies, refer to Note 2 — “Summary of Significant Accounting Policies,” in our financial statements included in Company’s 2020 Form 10-K. During the three and nine-months ended November 30, 2020, the Company recognized aggregate gains of approximately $2.7 million in connection with the cancellation of certain accounts payable balances and accrued payroll related to unpaid wages and salaries and approximately $0.9 million in connection with demand promissory notes with three persons for which the respective statute of limitations periods have expired.

2700000

900000

Earnings Per Share The following table sets forth the basic and dilutive earnings per share for the nine-months ended November 30, 2020. The dilutive earning per share includes only the dilutive incremental effect of additional shares issued on an “as if converted basis” in relation to the convertible notes payable principal amounts outstanding as of November 30, 2020 (see Notes 3 and 6). The three-months ended November 30, 2020 was not included in the following table as the effect is anti-dilutive. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine-Months Ended November 30, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Income</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Per-share</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Numerator)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">(denominator)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif">Basic EPS</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Income available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1,527,562</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">59,803,498</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">0.03</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Effect of Dilutive Securities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Convertible notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17,155</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,380,112</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.01</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Dilutive EPS</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">Income available to common stockholders plus assumed conversions</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,544,716</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">61,183,610</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.03</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table>

Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Reclassifications Certain prior period amounts have been reclassified to conform to the current year presentation.

Recently Issued Accounting Pronouncements In June 2016, the FASB issued Accounting Standards Update 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instrument. Subsequent to the issuance of ASU 2016-13, the FASB clarified the guidance through several ASUs. The collective new guidance (ASC 326) generally requires entities to use a current expected credit loss model, which is a new impairment model based on expected losses rather than incurred losses. Under this model, an entity would recognize an impairment allowance equal to its current estimate of all contractual cash flows that the entity does not expect to collect. The entity’s estimate would consider relevant information about past events, current conditions, and reasonable and supportable forecasts. ASC 326 is effective for annual and interim fiscal reporting periods beginning after December 15, 2022, with early adoption permitted for annual reporting periods beginning after December 15, 2018. The Company is continuing to evaluate the expected impact of this ASC 326 but does not expect it to have a material impact on its financial statements upon adoption.

1527562

59803498 17155 1380112 0.01

1544716

61183610 0.03

NOTE 2 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company is reporting in this Quarterly Report operating losses of approximately $326,000 and $1,189,000 for the three and nine-months ended November 30, 2020, respectively, and negative cash flow from operating activities of approximately $1,246,000 for the nine-months ended November 30, 2020; such factors raise substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to generate profits on a sustained basis and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether. Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to retain its current financing, to obtain additional financing, and ultimately to attain profitability. Beginning with the second quarter of Fiscal 2020, we increased operations of our AuraGen®/VIPER business and revenue for the three and nine-months ended November 30, 2020 of Fiscal 2021 was approximately $7,800 and $61,000, respectively, as compared to approximately $397,000 and $745,000 of revenue in the comparable periods of Fiscal 2020.

326000

1189000

1246000

7800

61000

397000

745000

NOTE 3 – NOTES PAYABLE Non-related party and related party notes payable principal and accrued interest amounts consisted of the following: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in">Non-Related Party Promissory Notes (see below)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">November 30, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">February 29, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Demand promissory notes payable with 1 and 4 individuals as of November 30, 2020 and February 29, 2020, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">10,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">768,537</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Messrs. Abdou notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">150,181</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">215,181</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">U.S. Payroll Protection Plan loan program</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">74,405</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">U.S. Small Business Administration-Economic Injury Disaster Loan</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">152,256</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.375in; text-align: left">Total Demand and Notes Payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">386,842</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">983,718</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">264,462</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">264,462</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">133,178</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">133,178</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">945,825</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">945,825</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">59,506</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">59,506</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total Convertible Promissory Notes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,402,971</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,402,971</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accrued Interest - convertible, demand and notes payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">217,972</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">498,698</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total Non-Related Party</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,007,785</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,885,387</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Notes Payable-Related Party (see Note 6)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,375,925</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,262,911</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Kopple Notes Payable-related party, see Kopple Notes, Note 6:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11,114,892</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,494,933</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Mel Gagerman Notes Payable, see Gagerman, Note 6:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">144,628</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">139,026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">On November 20, 2019, the Company entered into a preliminary  agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">700,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">700,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total Related Party</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,335,444</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,596,871</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total notes payable and accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,343,229</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,482,258</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(12,742,533</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(12,816,376</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 4pt">Long-term portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,600,696</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,665,882</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table> Demand Promissory Notes and Notes Payable Demand promissory notes as of November 30 and February 29, 2020 are for one and four individuals, respectively, issued in September 2015 that are payable on demand with an interest rate of 10% per annum. As of November 30, 2020, the one individual is for the principal amount owed to the Mr. Zeitlin, a former director of the Company, of $10,000. In the nine-months ended November 30, 2020, $758,537 of demand notes principal and $385,349 of accrued interest were reversed as the related statute of limitations were determined to have expired. This reversal resulted in an aggregate reduction of current liabilities of $1,143,886, the recording of an issuance of 192,641 shares of common stock on the Condensed Balance Sheet as of November 30, 2020, and the recognition of $871,887 as gain on extinguishment of debt on the Condensed Statements of Operations for the nine-months ended November 30, 2020. Abdou and Abdou On June 20, 2013, the Company entered into an agreement with two individuals, Mr. M. Abdou and Mr. W. Abdou, for the sale of $125,000 of secured convertible notes payable (the “Notes”) and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $24,470 as a discount, which has been fully amortized. There is a remaining balance of $125,000 as of February 28, 2019. In 2016, the Company and the Company’s former Chief Executive Officer, Melvin Gagerman, were named among several other defendants in a lawsuit filed by Messrs. Abdou demanding repayment of loans totaling $125,000 plus accrued interest and exemplary damages. In January 2017, the Company entered into an agreement with all secured creditors other than Mr. W. Abdou and Mr. M. Abdou. In September 2018, the court entered a judgment of approximately $235,000 plus legal fees of in favor of the Messrs. Abdou. The Company subsequently appealed this judgment and, in September 2019, reached a settlement agreement with these creditors for a principal amount of $325,000, of which approximately $150,000 and $215,000 were outstanding as of November 30 and February 29, 2020, respectively. Paycheck Protection Plan Loan During April 2020, the Company ceased operations for approximately 6 weeks in compliance with State of California and the County of Orange public health pronouncements associated with the COVID-19 pandemic. On April 23, 2020, we obtained a Paycheck Protection Program (“PPP”) loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company intends to use the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. While we intend to apply for the forgiveness of the PPP Loan, there is no assurance that we will obtain forgiveness of the PPP Loan in whole or in part. As of November 30, 2020, $24,802 was classified as notes payable, non-current and $49,603 was classified as part of notes payable, current portion. Economic Injury Disaster Loan Entities negatively impacted by the COVID-19 pandemic were eligible to apply for loans sponsored by the United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL Loan”) program. On July 1, 2020, the Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; and there is no prepayment penalty or fees. As of November 30, 2020, the amount outstanding including accrued interest of $2,356 is $152,256 and is classified as part of notes payable, non-current on the November 30, 2020 balance sheet. Convertible Notes Payable Kenmont Capital Partners On May 7, 2013, the Company transferred 4 notes payable with a total principal value of $1,000,000 together with accrued interest, and consulting fees to a senior secured convertible note with a principal value of $1,087,000 (“New Kenmont Note”) and warrants to Kenmont Capital Partners LP. The New Kenmont Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. The Company recorded $342,020 as a discount, which has been fully amortized. There was a remaining balance of $549,954 as of November 30 and February 29, 2020, respectively. LPD Investments On May 7, 2013, the Company transferred 2 note payables with a total principal value of $550,000 together with accrued interest to a senior secured convertible note with a principal value of $558,700 (“New LPD Note”) and warrants to LPD Investments, Ltd. The New LPD Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants were subsequently exercised. The Company recorded $175,793 as a discount, which has been fully amortized. There is a remaining balance of $163,677 as of November 30 and February 29, 2020, respectively. Guenther On May 7, 2013, the Company entered into an agreement with an individual, Mr. Guenther, for the sale of $750,000 of secured convertible note payable (the “Note”) and warrants. The Note had a 1-year maturity date and was convertible into shares of common stock at the conversion price of $0.75 per share. The warrants entitle the holder to acquire 1,000,000 shares and have an initial exercise price of $0.75 per share and have a 7-year term. The Company recorded $235,985 as a discount, which has been fully amortized. There is a remaining balance of $232,194 as of November 30 and February 29, 2020, respectively. Dresner and Lempert On June 20, 2013, the Company entered into an agreement with two individuals, Mr. Dresner and Dr. Lempert, for the sale of $200,000 of secured convertible notes payable (the “Notes”) and warrants. The Notes had a 1-year maturity date and were convertible into shares of common stock at the conversion price of $0.50 per share. The warrants were subsequently exercised. The Company recorded $39,152 as a discount, which has been fully amortized. During Fiscal 2020, Dr. Lempert converted his share of the amount outstanding into common shares and the balance outstanding of $59,506 as of November 30 and February 29, 2020, respectively, is for Dresner exclusively. Dalrymple – August 2012 On August 10, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $1,000,000 of unsecured Convertible Promissory Note. The Convertible Promissory Note balance together with all accrued interest thereon was due and payable on August 10, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%.  The Company recorded $310,723 as a debt discount, which will be amortized over the life of the note. There is a remaining balance of $264,462 as of November 30 and February 29, 2020, respectively. Dalrymple – October 2012 On October 2, 2012, the Company entered into an agreement with an individual, Mr. Dalrymple, for the sale of $500,000 of unsecured Convertible Promissory Note. This Convertible Promissory Note balance together with all accrued interest thereon was due and payable on October 2, 2017 and the annual interest rate was 7% per annum and was due to be repaid 5 years from the closing date. On January 11, 2018, the note was renegotiated with a final payment date of January 11, 2023 with an annual interest rate of 5%. The Company recorded $137,583 as a debt discount, which will be amortized over the life of the note. There is a remaining balance of $133,178 as of November 30 and February 29, 2020, respectively. On January 30, 2017, the Company entered into an agreement entitled First Amendment to Transaction Documents with five of seven secured creditors holding a security interest in all of the Company’s assets except for its patents and other intellectual properties. All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a “Required Cash Payment” as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of November 30 and February 29, 2020, respectively, plus any outstanding accrued interest.

0.10

10000

1143886

192641

871887

125000

P1Y

0.50

24470

125000

235000

325000

150000 215000

1000000

1087000

P1Y

0.75

342020

549954

550000

558700

P1Y

0.75

175793

163677

750000

P1Y

0.75

1000000

0.75

P7Y

235985

232194

200000

P1Y

0.50

39152

59506

1000000

0.07

P5Y

0.05

310723

264462

500000

0.07

P5Y

0.05

137583 133178

All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a “Required Cash Payment” as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of November 30 and February 29, 2020, respectively, plus any outstanding accrued interest.

we obtained a Paycheck Protection Program (“PPP”) loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company intends to use the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. While we intend to apply for the forgiveness of the PPP Loan, there is no assurance that we will obtain forgiveness of the PPP Loan in whole or in part. As of November 30, 2020, $24,802 was classified as notes payable, non-current and $49,603 was classified as part of notes payable, current portion.

In the nine-months ended November 30, 2020, $758,537 of demand notes principal and $385,349 of accrued interest were reversed as the related statute of limitations were determined to have expired.

the Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; and there is no prepayment penalty or fees. As of November 30, 2020, the amount outstanding including accrued interest of $2,356 is $152,256 and is classified as part of notes payable, non-current on the November 30, 2020 balance sheet.

0.10

163677 232194 59506 264462 133178

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in">Non-Related Party Promissory Notes (see below)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">November 30, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">February 29, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Demand promissory notes payable with 1 and 4 individuals as of November 30, 2020 and February 29, 2020, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">10,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">768,537</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Messrs. Abdou notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">150,181</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">215,181</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">U.S. Payroll Protection Plan loan program</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">74,405</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">U.S. Small Business Administration-Economic Injury Disaster Loan</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">152,256</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.375in; text-align: left">Total Demand and Notes Payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">386,842</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">983,718</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">264,462</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">264,462</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">133,178</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">133,178</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">945,825</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">945,825</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">59,506</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">59,506</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total Convertible Promissory Notes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,402,971</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,402,971</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accrued Interest - convertible, demand and notes payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">217,972</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">498,698</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total Non-Related Party</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,007,785</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,885,387</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Notes Payable-Related Party (see Note 6)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,375,925</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,262,911</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Kopple Notes Payable-related party, see Kopple Notes, Note 6:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11,114,892</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,494,933</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Mel Gagerman Notes Payable, see Gagerman, Note 6:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">144,628</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">139,026</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">On November 20, 2019, the Company entered into a preliminary  agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">700,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">700,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total Related Party</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,335,444</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,596,871</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total notes payable and accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,343,229</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,482,258</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(12,742,533</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(12,816,376</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 4pt">Long-term portion</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,600,696</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,665,882</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table>

10000 768537 150181 215181 74405 152256 386842 983718 264462 264462 133178 133178 945825 945825 59506 59506

1402971

217972

498698

2007785 2885387

3375925

3262911

11114892

10494933

144628

139026

700000

15335444 14596871 17343229 17482258

12742533

12816376

4600696

4665882

2023-01-11

0.76

0.05

2023-01-11

0.76

0.05

2023-01-11

0.75

0.05

2023-01-11

0.50

0.05

700000

NOTE 4 – ACCRUED EXPENSES Accrued expenses consisted of the following as of the period referenced below: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">November 30, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">February 29, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Accrued payroll and related expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">634,114</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1,868,928</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued legal expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income taxes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,035</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,035</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">49,439</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">50,327</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">730,588</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,946,290</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table> Accrued payroll and related expenses consist primarily of salaries and vacation time accrued but not paid to employees due to our lack of financial resources. In the second quarter of fiscal year 2021, liabilities with respect to approximately $1.3 million in accrued payroll and related expenses were reversed as the related statute of limitation periods were determined to have expired.

1300000

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">November 30, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">February 29, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Accrued payroll and related expenses</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">634,114</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1,868,928</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued legal expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income taxes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,035</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,035</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">49,439</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">50,327</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">730,588</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,946,290</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table>

634114

1868928

20000

27035

49439

50327

NOTE 5 – SHAREHOLDERS’ EQUITY Common Stock During the three and nine-months ended November 30, 2020, the Company issued approximately 2,700,000 and 7,925,000 shares of common stock, respectively, for $405,000 and $1,220,000 in cash, respectively. During the three and nine-months ended November 30, 2019, the Company issued approximately 725,000 and 1,383,015 shares of common stock, respectively, for $144,980 and $295,333 in cash, respectively. During August 2019, 1,030,385 shares were issued for a settlement valued at $329,723 and during August 2020, 192,641 shares were issued in connection with the Veen settlement (see Note 3). In November 2019, 168,380 shares of common stock were issued to investors in settlement of debt and accrued interest valued at approximately $34,000. Employee Options and Warrants The 2006 Employee Stock Option Plan In September 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan, subject to shareholder approval, which was obtained at a special shareholders meeting in 2009. Under the 2006 Plan, the Company may grant options for up to the greater of three million or 10% of the number of shares of the Common Stock of Aura from time to time outstanding. As of February 29, 2020, and November 30, 2020, there were no stock options outstanding. The 2011 Director and Executive Officers Stock Option Plan In October 2011, shareholders approved the 2011 Director and Executive Officers Stock Option Plan at the Company’s annual meeting. Under the 2011 Plan, the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the nine-months ended November 30, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant. The following table provides the assumptions required to apply the Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Issued During the Nine-Months ended November 30, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 88%">Exercise Price</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">      0.25</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif">Share Price</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.16</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Volatility %</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">225</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.57</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected term (yrs.)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> The aggregate fair value of the 1,250,000 options granted in March 2020 is approximately $194,000, or $0.155 per option, with $18,875 and $193,750 recorded as part of sales, general and administration expense during the three and nine-months ended November 30, 2020, respectively. No stock-based compensation expense was recorded during Fiscal 2020. The following tables provide additional information regarding stock options outstanding and exercisable under the 2011 Director and Executive Officers Stock Option Plan: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Intrinsic Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left; padding-bottom: 1.5pt">Outstanding, February 29, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1,040,001</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">     -</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.25</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Exrecised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Outstanding, November 30, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,290,001</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.77</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Range of Exercise Price</td> <td> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Stock Options Outstanding</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Stock Options Exercisable</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Life</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted Average Exercise Price of Options Outstanding</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted Average Exercise Price of Options Exercisable</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">0.25 to $1.40</td> <td style="width: 1%"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">2,290,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">2,290,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 15%; text-align: center">3.25 Yrs.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.77</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.77</td><td style="width: 1%; text-align: left"> </td></tr> </table> Warrants Historically, warrants have been issued to investors and others for services and enticements to invest funds with the Company. Generally, these warrants fully vest immediately or within a 90-day period from the date of grant and have an expiration date of five-years from the date of grant. With grants dated prior to Fiscal 2021, an exercise price of $1.40 has been used with all warrants. No warrants were issued in the nine-months ended November 30, 2020. Activity in issued and outstanding warrants is as follows for the nine-months ended November 30, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Outstanding, February 29, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">5,816,939</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Exrecised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Outstanding, November 30, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,816,939</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table> Other information related to the warrants outstanding and exercisable as of November 30, 2020 follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Range of Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Stock Warrants Outstanding</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Stock Warrants Exercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Weighted Average Remaining Contractual Life</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Weighted Average Exercise Price of Warrants Outstanding</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Weighted Average Exercise Price of Warrants Exercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">5,816,939</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">5,816,939</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"> 2.19 Yrs. </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> </table>

2700000

7925000

405000

1220000

725000

1383015

144980

295333

1030385 329723 192641 168380 34000 Under the 2006 Plan, the Company may grant options for up to the greater of three million or 10% of the number of shares of the Common Stock of Aura from time to time outstanding. As of February 29, 2020, and November 30, 2020, there were no stock options outstanding. Under the 2011 Plan, the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the nine-months ended November 30, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant. The aggregate fair value of the 1,250,000 options granted in March 2020 is approximately $194,000, or $0.155 per option, with $18,875 and $193,750 recorded as part of sales, general and administration expense

1.40

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Issued During the Nine-Months ended November 30, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 88%">Exercise Price</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">      0.25</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif">Share Price</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.16</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Volatility %</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">225</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.57</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected term (yrs.)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>

0.25

0.16

2.25

0.0057

P4Y

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Intrinsic Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left; padding-bottom: 1.5pt">Outstanding, February 29, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1,040,001</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">     -</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.25</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Exrecised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Outstanding, November 30, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,290,001</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.77</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table>

1040001

1.40

1250000

0.25

2290001

0.77

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Range of Exercise Price</td> <td> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Stock Options Outstanding</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Stock Options Exercisable</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted Average Remaining Contractual Life</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted Average Exercise Price of Options Outstanding</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted Average Exercise Price of Options Exercisable</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">0.25 to $1.40</td> <td style="width: 1%"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">2,290,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">2,290,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 15%; text-align: center">3.25 Yrs.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.77</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">0.77</td><td style="width: 1%; text-align: left"> </td></tr> </table>

0.25

1.40

2290001

P3Y3M

0.77

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Outstanding, February 29, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">5,816,939</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Exrecised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Outstanding, November 30, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,816,939</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table>

5816939

1.40

5816939

1.40

5816939

P2Y69D

1.40 1.40

NOTE 6 – RELATED PARTIES TRANSACTIONS Notes payable-related party, non-current - $3,000,000 on the condensed balance sheets as of November 30 and February 29, 2020 consists of the Breslow Note as described below: Breslow Note On January 24, 2017, the Company entered into a Debt Refinancing Agreement with Mr. Breslow, a former Director of the Company. Pursuant to the agreement, both Mr. Breslow and the Company acknowledged that total debt owed to Mr. Breslow was $23,872,614 including $8,890,574 of accrued interest. Mr. Breslow agreed to cancel and forgive all interest due, waive all events of default and sign a new five-year convertible note in the amount of $14,982,041 providing for no interest for six months and interest of 5% per annum thereafter payable monthly in arrears. The note also provides various default provisions. In accordance with the agreement, on February 14, 2018, the effective date of the 1-for-7 reverse stock split, $11,982,041 of the note was converted into 7,403,705 shares of common stock and the then accrued interest of $9,388,338 was forgiven. A new $3,000,000 convertible five-year note representing the remaining balance was entered into at a conversion rate of $1.40. The note bears interest at a rate of 5% per annum payable monthly in arrears with accrued interest of $375,925 and $262,911 recorded as accrued interest-related party (see Note 4) as of November 30 and February 29, 2020, respectively. Notes payable and accrued interest-related party, current - $11,960,097 on the condensed balance sheet as of November 30 and $11,333,960 as of February 29, 2020 consists of the Kopple Notes, the Gagerman Note and the Jiangsu Shengfeng Note as set forth below: Kopple Notes As of November 30, and February 29, 2020, the principal amount owed to Robert Kopple (former Vice-Chairman of our Board) of $5,607,323 was unchanged. As of November 30, 2020, accrued interest of $5,507,569 was owed to Mr. Kopple for a total balance of $11,114,892. As of February 29, 2020, accrued interest of $4,887,610 was owed to Mr. Kopple for a total balance of $10,494,933. On August 19, 2013, the Company entered into an agreement with Robert Kopple, a former member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Kopple Notes”) and warrants. The Kopple Notes carried a base interest rate of 9.5%, have a 4-year maturity date and were convertible into shares of common stock at the conversion price of $3.50 per share (conversion feature expired in 2017). The warrants were subsequently exercised. The Company recorded $667,118 as a discount, which has been fully amortized. The Company also entered into a demand note payable with this individual in the amount of $20,000, which bears interest at a rate of 5% per annum. Gagerman Note On November 30, 2020, the Gagerman note consisted of $82,000 of unsecured note payable plus accrued interest of $62,628 for a total owed to Melvin Gagerman of $144,628, the Company’s former CEO and CFO, pursuant to a demand note entered into on April 5, 2014. Interest accrues at 10% per annum. On February 29, 2020, the amount owed to Gagerman was $139,026. Jiangsu Shengfeng Note On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture, to return $700,000 previously advanced to the Company in September 2018 and recorded as part of customer advance on the balance sheet as of February 28, 2019. Following this agreement which would consists of a non-interest-bearing promissory note and a payment plan pursuant to which the $700,000 would be paid over a 12-month period. Principal loan amount on November 30, 2020 and February 29, 2020 was $700,000, respectively, and is classified as part of notes payable and accrued interest-related party, current on the balance sheets as of November 30, 2020. Accrued expense-related party – In the second quarter of Fiscal 2021, liabilities with respect to approximately $1,008,000 in accrued payroll and related expenses to former officers of the Company were reversed to other income in the Condensed Statement of Operations for the nine-months ended November 30, 2020 as the related statute of limitation periods were determined to have expired.

23872614

8890574

P5Y

14982041

0.05

1-for-7 reverse stock split

11982041

7403705

9388338

3000000

P5Y

1.40

0.05

375925 375925 262911 262911

5607323

5507569 11114892 4887610 10494933

the Company entered into an agreement with Robert Kopple, a former member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Kopple Notes”) and warrants. The Kopple Notes carried a base interest rate of 9.5%, have a 4-year maturity date and were convertible into shares of common stock at the conversion price of $3.50 per share (conversion feature expired in 2017). The warrants were subsequently exercised. The Company recorded $667,118 as a discount, which has been fully amortized. The Company also entered into a demand note payable with this individual in the amount of $20,000, which bears interest at a rate of 5% per annum.

82000

62628 144628 0.10 139026 700000

700000

1008000

NOTE 7 – COMMITMENTS & CONTINGENCIES Leases Our facilities consist of approximately 20,000 square feet in Stanton, California and, prior to July 31, 2020, an additional storage facility in Santa Clarita, California. The Stanton facility is used for assembly and testing of AuraGen®/VIPER systems and is rented on a month-to-month basis at $10,000 per month. Prior to July 2020, the Company paid $5,000 per month, also on a month-to-month basis, for the Santa Clarita storage facility. Following the closure of this facility, the Company is currently renting on a month-to-month basis approximately 1,000 square feet of temporary offsite storage space at a monthly cost of approximately $2,500. Commencing in February 2019 and ending in July 2019, the Company rented approximately 300 square feet of office space in Irvine, California at a cost of $ 2,350 per month on a month-to-month basis. Following the adoption of Topic 842, Leases, as of the start of Fiscal 2020, the Company determined that there was no impact on its Condensed Financial Statements during the fiscal year ended February 29, 2020, and as of November 30, 2020, it is management’s intention to vacate the existing facilities and consolidate operations at a different location as soon as practical. The standard requires entities to evaluate all lease transactions including leases previously classified as operating leases, and, if required under Topic 842, a right-to-use asset and a corresponding lease liability to be recorded on the balance sheet in the period in which a lease commences. Contingencies We are subject to the legal proceedings and claims discussed below as well as certain other legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and evaluates potential losses on such litigation if the amount of the loss is estimable and the loss is probable. However, the outcome of legal proceedings and claims brought against the Company is subject to significant uncertainty. Although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against the Company for amounts in excess of management’s expectations, the Company’s financial statements for that reporting period could be materially adversely affected. In 2017, the Company’s former COO was awarded approximately $238,000 in accrued salary and related charges by the California labor board. The Company believes that this award does not reflect the amount owed which is significantly lower and is exploring all its options and available remedies and is working toward an offer to settle this matter. The Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $11.1 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura’s behalf; and approximately $5 million Mr. Kopple claims to be owed for interest, loan fees and late payment charges) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company. In July 2017, Mr. Kopple filed suit against the Company as well as against current director Mr. Diaz-Verson and former directors Mr. Breslow and Mr. Howsmon, as well as Mr. Gagerman, our former CEO and a former director, in connection with these allegations. In 2018, the Court dismissed Mr. Diaz-Verson, Mr. Breslow, Mr. Howsmon and Mr. Gagerman from the suit. While the Company believes that it has certain valid defenses in these matters, the Company is currently in settlement discussions with Mr. Kopple. However, to-date, no settlement has been reached in large part because Mr. Kopple continues to demand that as part of any such settlement, he receive unilateral control over significant aspects of the Company’s financial and management functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company’s management team and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’ duties to shareholders and creditors as a whole. In May 2018, Shelley Scholnick dba JB Transporters brought suit against the Company claiming ongoing fees in excess of $52,000 owed for the storage of the Company’s property. Notably, in June 2017, the Company had brought suit against J.B. Moving & Delivery, a business operated and controlled by a relative of Scholnick, Jacob Binstok, for damages suffered by the Company as a result of the defendant’s improper storage of the Company’s property and improper refusal to return such property. In 2018, the Company successfully received a judgment against J.B. Moving & Delivery in the amount of approximately $114,000. In April 2020, Aura and Scholnick entered into a Confidential Settlement and Release Agreement wherein (i) the 2018 action initiated by Scholnick against Aura was resolved with no amounts owing by Aura and the complaint and cross-complaint were subsequently dismissed with prejudice; and (ii) the amount owing to Aura pursuant to the judgment against J.B. Moving and Delivery was compromised and resolved through a single lump-sum payment to Aura. On March 26, 2019, various stockholders of the Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company.  On March 27, 2019, those same stockholders delivered a further signed written consent to the Company removing William Anderson and Si Ryong Yu as members of the Company’s Board and electing Robert Lempert and David Mann as directors of the Company. These written consents represented a majority of the outstanding shares of the Company’s common stock as of March 26, 2019 and March 27, 2019, respectively. Because of Aura’s refusal to recognize the legal effectiveness of the consents, on April 8, 2019 the stockholders filed suit in the Court of Chancery of the State of Delaware pursuant to Section 225 of the Delaware General Corporations Law, seeking an order confirming the validity of the consents and declaring that Aura’s Board consists of Ms. Lavut, Mr. Mann, Dr. Lempert, Mr. Douglas and Mr. Diaz-Versón, Jr. On July 8, 2019 the Court of Chancery entered final judgment in favor of the stockholder plaintiffs, confirming that (a) Ronald Buschur, Si Ryong Yu and William Anderson had been validly removed by the holders of a majority of the Company’s outstanding stock acting by written consent (b) Ms. Lavut, Mr. Mann and Dr. Lempert had been validly elected by the holders of a majority of the Company’s outstanding stock acting by written consent, and (c) the Company’s Board of Directors validly consists of Cipora Lavut, David Mann, Robert Lempert, Gary Douglas and Salvador Diaz-Versón, Jr. As a result of prior management’s unsuccessful opposition to this stockholders’ action filed in the Court of Chancery, such stockholders may be potentially entitled to recoup their litigation costs from the Company under Delaware’s corporate benefit doctrine and/or other legal provisions. To-date, no final determination has been made as to the amount of recoupment, if any, to which such stockholders may be entitled.

20000

10000

5000

1000

2500

300

2350

238000

52000 114000 the Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company. 27500000

EX-101.SCH 6 ausi-20201130.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statements of Shareholders' Deficit (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Notes Payable link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Related Parties Transactions link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Details) - Schedule of earnings Per Share link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Accrued Expenses (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Accrued Expenses (Details) - Schedule of accrued expenses link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Shareholders' Equity (Details) - Schedule of Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Shareholders' Equity (Details) - Schedule of employee stock option plan link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Shareholders' Equity (Details) - Schedule of exercise price options outstanding link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Shareholders' Equity (Details) - Schedule of activity in issued and outstanding warrants link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Shareholders' Equity (Details) - Schedule of exercise prices warrants outstanding link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Related Parties Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Commitments & Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 ausi-20201130_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ausi-20201130_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ausi-20201130_lab.xml XBRL LABEL FILE Statement of Financial Position [Abstract] Total current assets Total assets Total current liabilities Total liabilities Total shareholders’ deficit Balance Balance Total liabilities and shareholders’ deficit Income Statement [Abstract] Gross profit Total operating expenses Loss from operations Income (loss) before income tax provision Net income (loss) Net income (loss) Statement of Cash Flows [Abstract] Cash used in operating activities Cash provided by financing activities Net decrease in cash and cash equivalents Beginning cash Ending cash Cash and cash equivalents Statement of Stockholders' Equity [Abstract] Balance (in Shares) Balance (in Shares) Equity Components [Axis] Nature Of Operations And Summary Of Significant Accounting Policies [Abstract] Schedule of earnings Per Share [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Debt Disclosure [Abstract] Schedule of non-related party and related party notes payable transaction [Abstract] Debt Instrument [Axis] Related Party [Axis] Payables and Accruals [Abstract] Schedule of accrued expenses [Abstract] Total Accrued expenses Stockholders' Equity Note [Abstract] Schedule of Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date [Abstract] Schedule of employee stock option plan [Abstract] Plan Name [Axis] Number of Shares, Outstanding, February 29, 2020 (in Shares) Number of Shares, Outstanding, August 31, 2020 | shares (in Shares) Exercise Prices, Outstanding, February 29, 2020 Exercise Price, Outstanding, August 31, 2020 Schedule of exercise price options outstanding [Abstract] Exercise Price Range [Axis] Statistical Measurement [Axis] Schedule of activity in issued and outstanding warrants [Abstract] Number of Shares, Outstanding, February 29, 2020 Number of Shares, Outstanding, November 30, 2020 Stock Warrants Outstanding (in Shares) Exercise Prices, Outstanding, February 28, 2019 Exercise Prices, Outstanding, November 30, 2020 Warrants exercise price (in Dollars per share) Schedule of exercise prices warrants outstanding [Abstract] Related Party Transactions [Abstract] Commitments and Contingencies Disclosure [Abstract] Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Emerging Growth Company Entity File Number Entity Filer Category Entity Incorporation, State or Country Code Entity Interactive Data Current Entity Registrant Name Entity Shell Company Entity Small Business Assets Current assets Inventory Other current assets Fixed Assets, net Liabilities & Shareholders’ Deficit Current liabilities Accounts payable Customer advances Accrued expense-related party Accrued interest-notes payable-related party Accrued interest-notes payable Notes payable, current portion Notes payable and accrued interest-related party Notes payable-related party Notes payable-related party, non-current Notes payable Convertible Note payable Convertible notes payable Commitments and contingencies (note 7) Shareholders’ deficit Common stock: $0.0001 par value; 150,000,000 shares authorized at November 30 and February 29, 2020; 64,518,512 and 56,400,874 issued and outstanding at November 30 and February 29, 2020, respectively Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Additional paid-in capital Accumulated deficit Net revenue Cost of goods sold Operating expenses Engineering, research & development Selling, general & administration Other (income) expense: Interest expense, net Other income Gain on extinguishment of debt Other (gains) losses from settlements Income tax provision Basic income (loss) per share (in Dollars per share) Per-share amount income available to common stockholders Weighted average shares outstanding-basic (in Shares) Dilutive income (loss) per share (in Dollars per share) Weighted average shares outstanding-dilutive (in Shares) Net income (loss) Adjustments to reconcile net income (loss) to cash used in operating activities Depreciation of fixed assets Stock-based compensation expense Changes in working capital assets and liabilities: Accrued interest on notes payable Accts payable, customer deposits and accrued expenses Cash flows from investing activities: Cash flows from financing activities: Issuance of common stock Proceeds from Federal PPP & SBA notes Cash paid in the period for: Interest Income taxes Supplemental schedule of non-cash transactions: Note payable converted into shares of common stock Convertible notes converted into shares of common stock Shares issued for cash Shares issued for cash (in Shares) Shares issued for settlement Shares issued for settlement (in Shares) Shares cancelled (in Shares) Number of Shares, Cancelled (in Shares) Shares issued for debt Shares issued for debt (in Shares) Stock-based compensation expense Loss on settlement of debt Gain on write-off of expired liabilities Inventory Other current assets Purchase of property, plant and equipment Payment on notes payable Shares cancelled Common Stock Common Stock [Member] Additional Paid-In Capital Accumulated Deficit NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Schedule of earnings Per Share Basic EPS Income (Numerator) income available to common stockholders Shares (denominator) income available to common stockholders Effect of Dilutive Securities Income (Numerator) convertible notes payable Shares (denominator) convertible notes payable Per-share amount convertible notes payable Dilutive EPS Income (Numerator income available to common stockholders plus assumed conversions Shares (denominator) income available to common stockholders plus assumed conversions Per-share amount income available to common stockholders plus assumed conversions GOING CONCERN NOTES PAYABLE Schedule of non-related party and related party notes payable transaction Demand and Notes Payble Notes payable interest rate Total Demand and Notes Payable Convertible Promissory Notes Converted instrument date Common stock at price (in Dollars per share) Total Convertible Promissory Notes Accrued Interest - convertible, demand and notes payable Total Non-Related Party Notes Payable-Related Party (see Note 6) Convertible notes payable (in Dollars) Total Related Party Total notes payable and accrued interest Long-term portion ACCRUED EXPENSES Schedule of accrued expenses Accrued payroll and related expenses Accrued legal expenses Income taxes payable Other accrued expenses SHAREHOLDERS’ EQUITY Schedule of Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date Exercise Price Range of Exercise Prices Share Price Volatility % Risk-free rate Expected term (yrs.) Schedule of employee stock option plan Number of Shares, Granted (in Shares) Exercise Prices, Granted EX-101.PRE 10 ausi-20201130_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information	9 Months Ended
Document And Entity Information	Nov. 30, 2020 shares
Document Information Line Items
Entity Registrant Name	AURA SYSTEMS INC
Document Type	10-Q
Current Fiscal Year End Date	--02-28
Entity Common Stock, Shares Outstanding	64,518,512
Amendment Flag	false
Entity Central Index Key	0000826253
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Nov. 30, 2020
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity File Number	000-17249
Entity Incorporation, State or Country Code	DE
Entity Interactive Data Current	No

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Unaudited) - USD ($)	Nov. 30, 2020	Feb. 29, 2020
Current assets
Cash and cash equivalents	$ 143,693	$ 19,807
Inventory	105,166	90,037
Other current assets	35,787	1,487
Total current assets	284,645	111,330
Fixed Assets, net	8,624
Total assets	293,269	111,330
Current liabilities
Accounts payable	1,873,745	2,537,061
Accrued expenses	730,588	1,946,290
Customer advances	440,331	440,331
Accrued expense-related party		1,008,328
Accrued interest-notes payable-related party	375,925	262,911
Accrued interest-notes payable	217,395	498,698
Notes payable, current portion	189,116	983,717
Notes payable and accrued interest-related party	11,960,097	11,333,960
Total current liabilities	15,787,197	19,011,296
Notes payable-related party	3,000,000	3,000,000
Notes payable	197,725	0
Convertible notes payable	1,402,971	1,402,971
Total liabilities	20,387,894	23,414,267
Commitments and contingencies (note 7)
Shareholders’ deficit
Common stock: $0.0001 par value; 150,000,000 shares authorized at November 30 and February 29, 2020; 64,518,512 and 56,400,874 issued and outstanding at November 30 and February 29, 2020, respectively	6,450	5,639
Additional paid-in capital	445,097,390	443,417,452
Accumulated deficit	(465,198,465)	(466,726,027)
Total shareholders’ deficit	(20,094,625)	(23,302,937)
Total liabilities and shareholders’ deficit	$ 293,269	$ 111,330

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Unaudited) (Parentheticals) - $ / shares	Nov. 30, 2020	Feb. 29, 2020
Statement of Financial Position [Abstract]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	64,518,512	56,400,874
Common stock, shares outstanding	64,518,512	56,400,874

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Income Statement [Abstract]
Net revenue	$ 7,829	$ 396,775	$ 61,462	$ 744,850
Cost of goods sold	5,320	115,655	46,718	147,752
Gross profit	2,510	281,119	14,743	597,097
Operating expenses
Engineering, research & development	70,217	30,472	169,318	123,024
Selling, general & administration	258,528	407,652	1,034,836	915,934
Total operating expenses	328,744	438,124	1,204,154	1,038,958
Loss from operations	(326,235)	(157,005)	(1,189,411)	(441,861)
Other (income) expense:
Interest expense, net	268,017	283,928	884,751	885,731
Other income	(4,391)	(107)	(2,683,805)	(107)
Gain on extinguishment of debt			(871,887)
Other (gains) losses from settlements	(32)	333,512	(46,032)	333,512
Income (loss) before income tax provision	(589,829)	(774,337)	1,527,562	(1,660,997)
Income tax provision
Net income (loss)	$ (589,829)	$ (774,337)	$ 1,527,562	$ (1,660,997)
Basic income (loss) per share (in Dollars per share)	$ (0.01)	$ (0.01)	$ 0.03	$ (0.03)
Weighted average shares outstanding-basic (in Shares)	62,664,666	55,296,222	59,803,498	54,012,831
Dilutive income (loss) per share (in Dollars per share)	$ (0.01)	$ (0.01)	$ 0.03	$ (0.03)
Weighted average shares outstanding-dilutive (in Shares)	62,664,666	55,296,222	61,183,610	54,012,831

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019
Statement of Cash Flows [Abstract]
Net income (loss)	$ 1,527,562	$ (1,660,996)
Adjustments to reconcile net income (loss) to cash used in operating activities
Loss on settlement of debt		329,723
Depreciation of fixed assets	297
Stock-based compensation expense	193,750
Gain on write-off of expired liabilities	(3,585,639)
Changes in working capital assets and liabilities:
Inventory	(15,129)	(53,163)
Other current assets	(34,300)	8,357
Accrued interest on notes payable	847,987	855,534
Accts payable, customer deposits and accrued expenses	(181,026)	29,966
Cash used in operating activities	(1,246,498)	(490,579)
Cash flows from investing activities:
Purchase of property, plant and equipment	(8,921)
Cash flows from financing activities:
Issuance of common stock	1,220,000	295,245
Payment on notes payable	(65,000)	(40,000)
Proceeds from Federal PPP & SBA notes	224,305
Cash provided by financing activities	1,379,305	255,245
Net decrease in cash and cash equivalents	123,886	(235,334)
Beginning cash	19,807	358,209
Ending cash	143,693	122,875
Cash paid in the period for:
Interest	2,500
Income taxes
Supplemental schedule of non-cash transactions:
Note payable converted into shares of common stock	267,000	13,159
Convertible notes converted into shares of common stock		$ 20,501

XML 16 R6.htm IDEA: XBRL DOCUMENT

Condensed Statements of Shareholders' Deficit (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Feb. 28, 2019	$ 5,371	$ 442,519,092	$ (464,119,162)	$ (21,594,699)
Balance (in Shares) at Feb. 28, 2019	53,714,145
Shares issued for cash	$ 15	49,985		50,000
Shares issued for cash (in Shares)	156,250
Net income (loss)			(675,321)	(675,321)
Balance at May. 31, 2019	$ 5,386	442,569,077	(464,794,483)	(22,220,020)
Balance (in Shares) at May. 31, 2019	53,870,395
Balance at Feb. 28, 2019	$ 5,371	442,519,092	(464,119,162)	(21,594,699)
Balance (in Shares) at Feb. 28, 2019	53,714,145
Net income (loss)				(1,660,997)
Balance at Nov. 30, 2019	$ 5,522	443,177,569	(465,780,159)	(22,597,068)
Balance (in Shares) at Nov. 30, 2019	55,230,874
Balance at May. 31, 2019	$ 5,386	442,569,077	(464,794,483)	(22,220,020)
Balance (in Shares) at May. 31, 2019	53,870,395
Shares issued for cash	$ 51	100,302		100,353
Shares issued for cash (in Shares)	501,765
Shares issued for settlement	$ 103	329,620		329,723
Shares issued for settlement (in Shares)	1,030,385
Net income (loss)			(211,339)	(211,339)
Balance at Aug. 31, 2019	$ 5,540	442,998,999	(465,005,822)	(22,001,283)
Balance (in Shares) at Aug. 31, 2019	55,402,545
Shares issued for cash	$ 73	144,928		145,001
Shares issued for cash (in Shares)	725,000
Shares cancelled	$ (107)			(107)
Shares cancelled (in Shares)	(1,065,051)
Shares issued for debt	$ 16	33,642		33,658
Shares issued for debt (in Shares)	168,380
Net income (loss)			(774,337)	(774,337)
Balance at Nov. 30, 2019	$ 5,522	443,177,569	(465,780,159)	(22,597,068)
Balance (in Shares) at Nov. 30, 2019	55,230,874
Balance at Feb. 29, 2020	$ 5,641	443,417,449	(466,726,027)	(23,302,937)
Balance (in Shares) at Feb. 29, 2020	56,400,874
Shares issued for cash	$ 135	234,865		235,000
Shares issued for cash (in Shares)	1,358,333
Stock-based compensation expense		77,599		77,599
Net income (loss)			(606,001)	(606,001)
Balance at May. 31, 2020	$ 5,776	443,729,913	(467,332,029)	(23,596,340)
Balance (in Shares) at May. 31, 2020	57,759,207
Balance at Feb. 29, 2020	$ 5,641	443,417,449	(466,726,027)	(23,302,937)
Balance (in Shares) at Feb. 29, 2020	56,400,874
Net income (loss)				1,527,562
Balance at Nov. 30, 2020	$ 6,452	445,097,387	(465,198,466)	(20,094,625)
Balance (in Shares) at Nov. 30, 2020	64,518,512
Balance at May. 31, 2020	$ 5,776	443,729,913	(467,332,029)	(23,596,340)
Balance (in Shares) at May. 31, 2020	57,759,207
Shares issued for cash	$ 387	579,613		580,000
Shares issued for cash (in Shares)	3,866,665
Stock-based compensation expense		96,476		96,476
Shares issued for settlement	$ 19	266,981		267,000
Shares issued for settlement (in Shares)	192,641
Net income (loss)			2,723,392	2,723,392
Balance at Aug. 31, 2020	$ 6,182	444,672,983	(464,608,637)	(19,929,472)
Balance (in Shares) at Aug. 31, 2020	61,818,513
Shares issued for cash	$ 270	404,730		405,000
Shares issued for cash (in Shares)	2,699,999
Stock-based compensation expense		19,674		19,674
Net income (loss)			(589,829)	(589,829)
Balance at Nov. 30, 2020	$ 6,452	$ 445,097,387	$ (465,198,466)	$ (20,094,625)
Balance (in Shares) at Nov. 30, 2020	64,518,512

XML 17 R7.htm IDEA: XBRL DOCUMENT

Nature of Operations and Summary of Significant Accounting Policies

9 Months Ended

Nov. 30, 2020

Nature Of Operations And Summary Of Significant Accounting Policies [Abstract]

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Basis of Presentation

Significant Accounting Policies

Earnings Per Share

	Nine-Months Ended November 30, 2020
	Income		Shares		Per-share
	(Numerator)		(denominator)		Amount
Basic EPS
Income available to common stockholders	$	1,527,562		59,803,498	$	0.03

Effect of Dilutive Securities
Convertible notes payable	$	17,155		1,380,112	$	0.01

Dilutive EPS
Income available to common stockholders plus assumed conversions	$	1,544,716		61,183,610	$	0.03

Use of Estimates

Reclassifications

Certain prior period amounts have been reclassified to conform to the current year presentation.

Recently Issued Accounting Pronouncements

XML 18 R8.htm IDEA: XBRL DOCUMENT

Going Concern

9 Months Ended

Nov. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GOING CONCERN

NOTE 2 – GOING CONCERN

XML 19 R9.htm IDEA: XBRL DOCUMENT

Notes Payable

9 Months Ended

Nov. 30, 2020

Debt Disclosure [Abstract]

NOTES PAYABLE

NOTE 3 – NOTES PAYABLE

Non-related party and related party notes payable principal and accrued interest amounts consisted of the following:

Non-Related Party Promissory Notes (see below)	November 30, 2020			February 29, 2020

Demand promissory notes payable with 1 and 4 individuals as of November 30, 2020 and February 29, 2020, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)	$	10,000		$	768,537
Messrs. Abdou notes payable		150,181			215,181
U.S. Payroll Protection Plan loan program		74,405			-
U.S. Small Business Administration-Economic Injury Disaster Loan		152,256			-
Total Demand and Notes Payable		386,842			983,718
Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.		264,462			264,462
Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.		133,178			133,178
Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.		945,825			945,825
Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.		59,506			59,506
Total Convertible Promissory Notes		1,402,971			1,402,971
Accrued Interest - convertible, demand and notes payable		217,972			498,698
Total Non-Related Party		2,007,785			2,885,387

Notes Payable-Related Party (see Note 6)
Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details		3,375,925			3,262,911
Kopple Notes Payable-related party, see Kopple Notes, Note 6:		11,114,892			10,494,933
Mel Gagerman Notes Payable, see Gagerman, Note 6:		144,628			139,026
On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.		700,000			700,000
Total Related Party		15,335,444			14,596,871
Total notes payable and accrued interest		17,343,229			17,482,258
Less: Current portion	$	(12,742,533	)	$	(12,816,376	)
Long-term portion	$	4,600,696		$	4,665,882

Demand Promissory Notes and Notes Payable

Abdou and Abdou

Paycheck Protection Plan Loan

Economic Injury Disaster Loan

Convertible Notes Payable

Kenmont Capital Partners

LPD Investments

Guenther

Dresner and Lempert

Dalrymple – August 2012

Dalrymple – October 2012

XML 20 R10.htm IDEA: XBRL DOCUMENT

Accrued Expenses

9 Months Ended

Nov. 30, 2020

Payables and Accruals [Abstract]

ACCRUED EXPENSES

NOTE 4 – ACCRUED EXPENSES

Accrued expenses consisted of the following as of the period referenced below:

	November 30, 2020		February 29, 2020
Accrued payroll and related expenses	$	634,114	$	1,868,928
Accrued legal expenses		20,000		-
Income taxes payable		27,035		27,035
Other accrued expenses		49,439		50,327
	$	730,588	$	1,946,290

XML 21 R11.htm IDEA: XBRL DOCUMENT

Shareholders' Equity

9 Months Ended

Nov. 30, 2020

Stockholders' Equity Note [Abstract]

SHAREHOLDERS’ EQUITY

NOTE 5 – SHAREHOLDERS’ EQUITY

Common Stock

Employee Options and Warrants

The 2006 Employee Stock Option Plan

The 2011 Director and Executive Officers Stock Option Plan

	Options Issued During the Nine-Months ended November 30, 2020

Exercise Price	$	0.25
Share Price	$	0.16
Volatility %		225	%
Risk-free rate		0.57	%
Expected term (yrs.)		4.0

The following tables provide additional information regarding stock options outstanding and exercisable under the 2011 Director and Executive Officers Stock Option Plan:

	Number of Shares		Exercise Price		Weighted Average Intrinsic Value
Outstanding, February 29, 2020		1,040,001	$	1.40	$	-
Granted		1,250,000		0.25		-
Exrecised		-		-		-
Cancelled		-		-		-
Outstanding, November 30, 2020		2,290,001	$	0.77	$	-

Range of Exercise Price				Stock Options Outstanding				Stock Options Exercisable				Weighted Average Remaining Contractual Life		Weighted Average Exercise Price of Options Outstanding				Weighted Average Exercise Price of Options Exercisable
$	0.25 to $1.40				2,290,001				2,290,001			3.25 Yrs.		$	0.77			$	0.77

Warrants

Activity in issued and outstanding warrants is as follows for the nine-months ended November 30, 2020:

	Number of Shares		Exercise Price
Outstanding, February 29, 2020		5,816,939	$	1.40
Granted		-		-
Exrecised		-		-
Cancelled		-		-
Outstanding, November 30, 2020		5,816,939	$	1.40

Other information related to the warrants outstanding and exercisable as of November 30, 2020 follows:

Range of Exercise Price				Stock Warrants Outstanding				Stock Warrants Exercisable				Weighted Average Remaining Contractual Life				Weighted Average Exercise Price of Warrants Outstanding				Weighted Average Exercise Price of Warrants Exercisable
$	1.40				5,816,939				5,816,939				2.19 Yrs.			$	1.40			$	1.40

XML 22 R12.htm IDEA: XBRL DOCUMENT

Related Parties Transactions

9 Months Ended

Nov. 30, 2020

RELATED PARTIES TRANSACTIONS

NOTE 6 – RELATED PARTIES TRANSACTIONS

Notes payable-related party, non-current - $3,000,000 on the condensed balance sheets as of November 30 and February 29, 2020 consists of the Breslow Note as described below:

Breslow Note

Kopple Notes

Gagerman Note

Jiangsu Shengfeng Note

XML 23 R13.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies

9 Months Ended

Nov. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS & CONTINGENCIES

NOTE 7 – COMMITMENTS & CONTINGENCIES

Leases

Commencing in February 2019 and ending in July 2019, the Company rented approximately 300 square feet of office space in Irvine, California at a cost of $ 2,350 per month on a month-to-month basis.

Contingencies

XML 24 R14.htm IDEA: XBRL DOCUMENT

Accounting Policies, by Policy (Policies)

9 Months Ended

Nov. 30, 2020

Accounting Policies [Abstract]

Nature of Operations

Nature of Operations

Basis of Presentation

Basis of Presentation

Significant Accounting Policies

Significant Accounting Policies

Earnings Per Share

Earnings Per Share

	Nine-Months Ended November 30, 2020
	Income		Shares		Per-share
	(Numerator)		(denominator)		Amount
Basic EPS
Income available to common stockholders	$	1,527,562		59,803,498	$	0.03

Effect of Dilutive Securities
Convertible notes payable	$	17,155		1,380,112	$	0.01

Dilutive EPS
Income available to common stockholders plus assumed conversions	$	1,544,716		61,183,610	$	0.03

Use of Estimates

Use of Estimates

Reclassifications

Reclassifications

Certain prior period amounts have been reclassified to conform to the current year presentation.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

XML 25 R15.htm IDEA: XBRL DOCUMENT

Nature of Operations and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Nov. 30, 2020

Nature Of Operations And Summary Of Significant Accounting Policies [Abstract]

Schedule of earnings Per Share

	Nine-Months Ended November 30, 2020
	Income		Shares		Per-share
	(Numerator)		(denominator)		Amount
Basic EPS
Income available to common stockholders	$	1,527,562		59,803,498	$	0.03

Effect of Dilutive Securities
Convertible notes payable	$	17,155		1,380,112	$	0.01

Dilutive EPS
Income available to common stockholders plus assumed conversions	$	1,544,716		61,183,610	$	0.03

XML 26 R16.htm IDEA: XBRL DOCUMENT

Notes Payable (Tables)

9 Months Ended

Nov. 30, 2020

Debt Disclosure [Abstract]

Schedule of non-related party and related party notes payable transaction

Non-Related Party Promissory Notes (see below)	November 30, 2020			February 29, 2020

Demand promissory notes payable with 1 and 4 individuals as of November 30, 2020 and February 29, 2020, respectively, carrying an interest rate of 10% (see Demand Promissory Notes below)	$	10,000		$	768,537
Messrs. Abdou notes payable		150,181			215,181
U.S. Payroll Protection Plan loan program		74,405			-
U.S. Small Business Administration-Economic Injury Disaster Loan		152,256			-
Total Demand and Notes Payable		386,842			983,718
Convertible Promissory Note originally dated August 10, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple August 2012 for further details.		264,462			264,462
Convertible Promissory Note originally dated October 2, 2012, due January 11, 2023, convertible into shares of our common stock at a price of $0.76 per share, carrying interest rate of 5%. See Convertible Promissory Notes – Dalrymple October 2012 for further details.		133,178			133,178
Senior secured convertible notes originally dated May 7, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.75 per share, carrying interest rate of 5%. See Convertible Debt – Kenmont Capital Partners, LPD Investments and Guenther for further details.		945,825			945,825
Senior secured convertible notes originally dated June 20, 2013, due January 11, 2023, convertible into shares of our common stock at a price of $0.50 per share, carrying interest rate of 5%. See Convertible Debt – Dresner and Lempert for further details.		59,506			59,506
Total Convertible Promissory Notes		1,402,971			1,402,971
Accrued Interest - convertible, demand and notes payable		217,972			498,698
Total Non-Related Party		2,007,785			2,885,387

Notes Payable-Related Party (see Note 6)
Convertible Note payable and accrued interest – related party, carrying an interest rate of 5% - see Note 6, Breslow Note, for further details		3,375,925			3,262,911
Kopple Notes Payable-related party, see Kopple Notes, Note 6:		11,114,892			10,494,933
Mel Gagerman Notes Payable, see Gagerman, Note 6:		144,628			139,026
On November 20, 2019, the Company entered into a preliminary agreement with Jiangsu Shengfeng, the Company’s Chinese joint venture. Payment terms consist of a non-interest bearing promissory note and a payment plan pursuant to which the $700,000 is paid over a 12-month period beginning March 15, 2020 through February 15, 2021.		700,000			700,000
Total Related Party		15,335,444			14,596,871
Total notes payable and accrued interest		17,343,229			17,482,258
Less: Current portion	$	(12,742,533	)	$	(12,816,376	)
Long-term portion	$	4,600,696		$	4,665,882

XML 27 R17.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Tables)

9 Months Ended

Nov. 30, 2020

Payables and Accruals [Abstract]

Schedule of accrued expenses

	November 30, 2020		February 29, 2020
Accrued payroll and related expenses	$	634,114	$	1,868,928
Accrued legal expenses		20,000		-
Income taxes payable		27,035		27,035
Other accrued expenses		49,439		50,327
	$	730,588	$	1,946,290

XML 28 R18.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Tables)

9 Months Ended

Nov. 30, 2020

Stockholders' Equity Note [Abstract]

Schedule of Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date

	Options Issued During the Nine-Months ended November 30, 2020

Exercise Price	$	0.25
Share Price	$	0.16
Volatility %		225	%
Risk-free rate		0.57	%
Expected term (yrs.)		4.0

Schedule of employee stock option plan

	Number of Shares		Exercise Price		Weighted Average Intrinsic Value
Outstanding, February 29, 2020		1,040,001	$	1.40	$	-
Granted		1,250,000		0.25		-
Exrecised		-		-		-
Cancelled		-		-		-
Outstanding, November 30, 2020		2,290,001	$	0.77	$	-

Schedule of exercise price options outstanding

Range of Exercise Price				Stock Options Outstanding				Stock Options Exercisable				Weighted Average Remaining Contractual Life		Weighted Average Exercise Price of Options Outstanding				Weighted Average Exercise Price of Options Exercisable
$	0.25 to $1.40				2,290,001				2,290,001			3.25 Yrs.		$	0.77			$	0.77

Schedule of activity in issued and outstanding warrants

	Number of Shares		Exercise Price
Outstanding, February 29, 2020		5,816,939	$	1.40
Granted		-		-
Exrecised		-		-
Cancelled		-		-
Outstanding, November 30, 2020		5,816,939	$	1.40

Schedule of exercise prices warrants outstanding

Range of Exercise Price				Stock Warrants Outstanding				Stock Warrants Exercisable				Weighted Average Remaining Contractual Life				Weighted Average Exercise Price of Warrants Outstanding				Weighted Average Exercise Price of Warrants Exercisable
$	1.40				5,816,939				5,816,939				2.19 Yrs.			$	1.40			$	1.40

XML 29 R19.htm IDEA: XBRL DOCUMENT

Nature of Operations and Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Nov. 30, 2020	Nov. 30, 2020
Nature Of Operations And Summary Of Significant Accounting Policies [Abstract]
Accounts payable	$ 2.7	$ 2.7
Accrued payroll related to unpaid wages and salaries	$ 0.9	$ 0.9

XML 30 R20.htm IDEA: XBRL DOCUMENT

Nature of Operations and Summary of Significant Accounting Policies (Details) - Schedule of earnings Per Share - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Schedule of earnings Per Share [Abstract]
Income (Numerator) income available to common stockholders			$ 1,527,562
Shares (denominator) income available to common stockholders			59,803,498
Per-share amount income available to common stockholders	$ (0.01)	$ (0.01)	$ 0.03	$ (0.03)
Income (Numerator) convertible notes payable			$ 17,155
Shares (denominator) convertible notes payable			1,380,112
Per-share amount convertible notes payable			$ 0.01
Income (Numerator income available to common stockholders plus assumed conversions			$ 1,544,716
Shares (denominator) income available to common stockholders plus assumed conversions			61,183,610
Per-share amount income available to common stockholders plus assumed conversions			$ 0.03

XML 31 R21.htm IDEA: XBRL DOCUMENT

Going Concern (Details) - USD ($)	3 Months Ended		9 Months Ended
Going Concern (Details) - USD ($)	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Operating losses	$ 326,000		$ 1,189,000
Negative cash flow from operating activities			1,246,000
Recognized revenue	$ 7,800	$ 397,000	$ 61,000	$ 745,000

XML 32 R22.htm IDEA: XBRL DOCUMENT

Notes Payable (Details) - USD ($)					1 Months Ended				3 Months Ended		9 Months Ended		12 Months Ended
Notes Payable (Details) - USD ($)	Jul. 01, 2020	May 07, 2013	Oct. 02, 2012	Aug. 10, 2012	Apr. 23, 2020	Sep. 30, 2018	Jan. 30, 2017	Jun. 20, 2013	Nov. 30, 2020	Nov. 30, 2019	Nov. 30, 2020	Nov. 30, 2019	Feb. 29, 2020	Feb. 28, 2019	Jan. 11, 2018
Notes Payable (Details) [Line Items]
Gain on extinguishment of debt											$ (871,887)
Remaining principle and interest balance													$ 232,194
Paycheck protection plan loan, Description					we obtained a Paycheck Protection Program (“PPP”) loan in the amount of approximately $74,400 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. The promissory note contains events of default and other provisions customary for a loan of this type. As required, the Company intends to use the PPP loan proceeds for payroll, healthcare benefits, rent and other qualifying expenses. The program provides that the use of PPP Loan amount shall be limited to certain qualifying expenses and may be partially or wholly forgiven in accordance with the requirements set forth in the CARES Act. While we intend to apply for the forgiveness of the PPP Loan, there is no assurance that we will obtain forgiveness of the PPP Loan in whole or in part. As of November 30, 2020, $24,802 was classified as notes payable, non-current and $49,603 was classified as part of notes payable, current portion.
Economic Injury Disaster Loan, description	the Company received cash proceeds of $149,900 under this program. The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accrues at 3.75% per annum effective July 1, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; The Company pledged the assets of the Company as collateral for the loan; and there is no prepayment penalty or fees. As of November 30, 2020, the amount outstanding including accrued interest of $2,356 is $152,256 and is classified as part of notes payable, non-current on the November 30, 2020 balance sheet.
Demand Promissory Notes Payable [Member]
Notes Payable (Details) [Line Items]
Notes payable interest rate									10.00%		10.00%		10.00%
Aggregate reduction of current liabilities									$ 1,143,886		$ 1,143,886
Issuance of common stock (in Shares)											192,641
Gain on extinguishment of debt											$ 871,887
Description of convertible promissory note											In the nine-months ended November 30, 2020, $758,537 of demand notes principal and $385,349 of accrued interest were reversed as the related statute of limitations were determined to have expired.
Convertible Notes Payable [Member] \| Kenmont Capital Partners [Member]
Notes Payable (Details) [Line Items]
Pre conversion debt principal amount		$ 1,000,000
Notes maturity date, term		1 year
Conversion price per share of notes payable (in Dollars per share)		$ 0.75
Amortization of debt discount		$ 342,020
Remaining principle and interest balance		549,954
Debt amount		1,087,000
Convertible Notes Payable [Member] \| LPD Investments, Ltd. [Member]
Notes Payable (Details) [Line Items]
Pre conversion debt principal amount		$ 550,000
Notes maturity date, term		1 year
Conversion price per share of notes payable (in Dollars per share)		$ 0.75
Amortization of debt discount		$ 175,793
Remaining principle and interest balance											$ 163,677		$ 163,677
Debt amount		558,700
Convertible Debt [Member]
Notes Payable (Details) [Line Items]
Description of convertible promissory note							All of the creditors entered into the January 30, 2017 agreement with the exception of Mr. W. Abdou and Mr. M. Abdou. The original agreement dated May 7, 2013 provided that if at least 75% of the stock issuable upon conversion of the convertible notes votes to amend the agreement and/or waive any conditions or defaults, then any such amendments or waivers shall be binding on all secured creditors. The five secured creditors signing the amendment total in excess of 95% of the issuable stock upon conversion and, therefore the agreement is binding on all seven of the secured creditors. The agreement provided that all accrued and unpaid interest will be added to the principal amount. The amended note provided for no interest from November 1, 2016 to February 14, 2018, the date at which the 1-for-7 reverse stock split became effective at which time 80% of the total debt including accrued interest was converted into shares of common stock and a new five year 5% per annum convertible note was issued for the remainder. The new amended and restated senior convertible notes have a maturity date of January 30, 2022. The five creditors and the Company entered into a Second Amendment to Transaction Documents on March 14, 2017 and a Third Amendment to Transaction Documents on April 8, 2017, both of which extended the required date of the stockholder approval of the 1-for-7 reverse stock split, which approval was obtained in January 2018. The amended and restated senior convertible notes also require the Company to make a “Required Cash Payment” as defined in the agreement if the Company receives at least $4,000,000 in aggregate gross proceeds from the sale of equity securities (including securities convertible into equity securities) of the Company in one or a series of related transactions. The Required Cash Payment is equal to the current outstanding balance of the notes, which was approximately $1,005,000 as of November 30 and February 29, 2020, respectively, plus any outstanding accrued interest.
Mr. Zeitlin [Member] \| Demand Promissory Notes Payable [Member]
Notes Payable (Details) [Line Items]
Principle amount											10,000
Abdou and Abdou [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Pre conversion debt principal amount								$ 125,000
Notes maturity date, term								1 year
Conversion price per share of notes payable (in Dollars per share)								$ 0.50
Amortization of debt discount								$ 24,470
Remaining principle and interest balance											150,000		215,000	$ 125,000
Amount of accrued interest								125,000
Judgment of approximately value plus legal fees						$ 235,000
Former Chief Executive Officers [Member] \| Secured creditors September 2019 [Member]
Notes Payable (Details) [Line Items]
Principle amount											325,000
Guenther [Member] \| Convertible Notes Payable [Member] \| Refinancing Agreements [Member]
Notes Payable (Details) [Line Items]
Pre conversion debt principal amount		$ 750,000
Notes maturity date, term		1 year
Conversion price per share of notes payable (in Dollars per share)		$ 0.75
Amortization of debt discount		$ 235,985
Remaining principle and interest balance											232,194
Number of common shares entitlement on exercise of warrant one (in Shares)		1,000,000
Term of warrant		7 years
Guenther [Member] \| Refinancing Agreements [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Conversion price per share of notes payable (in Dollars per share)		$ 0.75
Dresner and Lempert [Member] \| Convertible Notes Payable [Member]
Notes Payable (Details) [Line Items]
Pre conversion debt principal amount								$ 200,000
Notes maturity date, term								1 year
Conversion price per share of notes payable (in Dollars per share)								$ 0.50
Amortization of debt discount								$ 39,152
Remaining principle and interest balance											59,506		59,506
Dalrymple [Member] \| Convertible Notes Payable [Member] \| Unsecured Debt [Member]
Notes Payable (Details) [Line Items]
Notes payable interest rate			7.00%	7.00%											5.00%
Pre conversion debt principal amount			$ 500,000	$ 1,000,000
Notes maturity date, term			5 years
Amortization of debt discount				$ 310,723
Remaining principle and interest balance			$ 137,583								264,462		264,462
Dalrymple [Member] \| Convertible Debt [Member] \| Unsecured Debt [Member]
Notes Payable (Details) [Line Items]
Notes maturity date, term				5 years
Dalrymple [Member] \| Convertible Debt One [Member] \| Unsecured Debt [Member]
Notes Payable (Details) [Line Items]
Notes payable interest rate															5.00%
Remaining principle and interest balance											$ 133,178		$ 133,178

XML 33 R23.htm IDEA: XBRL DOCUMENT

Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction - USD ($)	Nov. 30, 2020	Feb. 29, 2020
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Total Demand and Notes Payable	$ 386,842	$ 983,718
Total Convertible Promissory Notes	1,402,971	1,402,971
Accrued Interest - convertible, demand and notes payable	217,972	498,698
Total Non-Related Party	2,007,785	2,885,387
Convertible Note payable	197,725	0
Demand Promissory Notes Payable [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Demand and Notes Payble	10,000	768,537
Messrs. Abdou notes payable [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Demand and Notes Payble	150,181	215,181
U.S. Payroll Protection Plan loan program [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Demand and Notes Payble	74,405
U.S. Small Business Administration-Economic Injury Disaster Loan [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Demand and Notes Payble	152,256
Convertible Promissory Note dated August 10, 2012 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Promissory Notes	264,462	264,462
Convertible Promissory Note originally dated October 2, 2012 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Promissory Notes	133,178	133,178
Senior secured convertible notes originally dated May 7, 2013 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Promissory Notes	945,825	945,825
Senior secured convertible notes originally dated June 20, 2013 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Promissory Notes	59,506	59,506
Notes Payable [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Note payable	3,375,925	3,262,911
Kopple Notes Payable-related party [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Note payable	11,114,892	10,494,933
Mel Gagerman Notes Payable [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Note payable	144,628	139,026
Jiangsu Shengfeng [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction [Line Items]
Convertible Note payable	700,000	700,000
Total Related Party	15,335,444	14,596,871
Total notes payable and accrued interest	17,343,229	17,482,258
Less: Current portion	(12,742,533)	(12,816,376)
Long-term portion	$ 4,600,696	$ 4,665,882

XML 34 R24.htm IDEA: XBRL DOCUMENT

Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) - USD ($)	9 Months Ended
	Nov. 30, 2020	Feb. 29, 2020
Demand Promissory Notes Payable [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	10.00%	10.00%
Convertible Promissory Note dated August 10, 2012 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	5.00%
Converted instrument date	Jan. 11, 2023
Common stock at price (in Dollars per share)	$ 0.76
Convertible Promissory Note originally dated October 2, 2012 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	5.00%
Converted instrument date	Jan. 11, 2023
Common stock at price (in Dollars per share)	$ 0.76
Senior secured convertible notes originally dated May 7, 2013 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	5.00%
Converted instrument date	Jan. 11, 2023
Common stock at price (in Dollars per share)	$ 0.75
Senior secured convertible notes originally dated June 20, 2013 [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	5.00%
Converted instrument date	Jan. 11, 2023
Common stock at price (in Dollars per share)	$ 0.50
Notes Payable [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Notes payable interest rate	5.00%
Jiangsu Shengfeng [Member]
Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) [Line Items]
Convertible notes payable (in Dollars)	$ 700,000

XML 35 R25.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Details) $ in Millions	Nov. 30, 2020 USD ($)
Payables and Accruals [Abstract]
Accrued payroll and related expenses	$ 1.3

XML 36 R26.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Details) - Schedule of accrued expenses - USD ($)	Nov. 30, 2020	Feb. 29, 2020
Schedule of accrued expenses [Abstract]
Accrued payroll and related expenses	$ 634,114	$ 1,868,928
Accrued legal expenses	20,000
Income taxes payable	27,035	27,035
Other accrued expenses	49,439	50,327
Total	$ 730,588	$ 1,946,290

XML 37 R27.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - USD ($)	3 Months Ended		6 Months Ended		9 Months Ended
Shareholders' Equity (Details) - USD ($)	Nov. 30, 2020	Nov. 30, 2019	Aug. 31, 2020	Aug. 31, 2019	Nov. 30, 2020	Nov. 30, 2019
Shareholders' Equity (Details) [Line Items]
Shares issued for debt settlement			192,641	1,030,385
Shares issued for debt settlement (in Dollars)				$ 329,723
Warrants exercise price, description					The aggregate fair value of the 1,250,000 options granted in March 2020 is approximately $194,000, or $0.155 per option, with $18,875 and $193,750 recorded as part of sales, general and administration expense
Warrants exercise price (in Dollars per share)	$ 1.40				$ 1.40
2006 Employee Stock Option Plan [Member]
Shareholders' Equity (Details) [Line Items]
Employee stock options, description					Under the 2006 Plan, the Company may grant options for up to the greater of three million or 10% of the number of shares of the Common Stock of Aura from time to time outstanding. As of February 29, 2020, and November 30, 2020, there were no stock options outstanding.
2011 Director and Executive Officers Stock Option Plan [Member]
Shareholders' Equity (Details) [Line Items]
Employee stock options, description					Under the 2011 Plan, the Company may grant options for up to 15% of the number of shares of Common Stock of the Company from time to time outstanding, with a contractual option term of five-years, and a vesting period not less than six-months and one day following date of grant. In the nine-months ended November 30, 2020, the Board of Directors approved grants of 250,000 stock options to each board member for an aggregate of 1,250,000 options, with an exercise price of $0.25 per option and at a market price of $0.16 on March 19, 2020, the date of grant.
Investor [Member]
Shareholders' Equity (Details) [Line Items]
Shares issued for debt settlement						168,380
Shares issued for debt settlement (in Dollars)						$ 34,000
Common Stock [Member]
Shareholders' Equity (Details) [Line Items]
Shares of common stock	2,700,000	725,000			7,925,000	1,383,015
Common stock for cash (in Dollars)	$ 405,000	$ 144,980
Common stock for cash (in Dollars)					$ 1,220,000	$ 295,333

XML 38 R28.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date	9 Months Ended
	Nov. 30, 2020 $ / shares
Schedule of Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date [Abstract]
Exercise Price	$ 0.25
Share Price	$ 0.16
Volatility %	225.00%
Risk-free rate	0.57%
Expected term (yrs.)	4 years

XML 39 R29.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of employee stock option plan - 2006 Plan [Member]	9 Months Ended
	Nov. 30, 2020 USD ($) $ / shares shares
Shareholders' Equity (Details) - Schedule of employee stock option plan [Line Items]
Number of Shares, Outstanding, February 29, 2020 (in Shares) \| shares	1,040,001
Exercise Prices, Outstanding, February 29, 2020	$ 1.40
Number of Shares, Granted (in Shares) \| shares	1,250,000
Exercise Prices, Granted	$ 0.25
Weighted Average Intrinsic Value, Granted
Number of Shares, Exercised (in Shares) \| shares
Exercise Prices, Exercised
Weighted Average Intrinsic Value, Exercised (in Dollars) \| $
Number of Shares, Cancelled (in Shares) \| shares
Exercise Prices, Cancelled
Weighted Average Intrinsic Value, Cancelled
Number of Shares, Outstanding, August 31, 2020 \| shares (in Shares) \| shares	2,290,001
Exercise Price, Outstanding, August 31, 2020	$ 0.77
Weighted Average Intrinsic Value, Outstanding, August 31, 2020 (in Dollars) \| $

XML 40 R30.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of exercise price options outstanding - 1.40 [Member]	9 Months Ended
	Nov. 30, 2020 $ / shares shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding (in Shares) \| shares	2,290,001
Stock Options Exercisable (in Shares) \| shares	2,290,001
Weighted Average Remaining Contractual Life	3 years 3 months
Weighted Average Exercise Price of Options Outstanding	$ 0.77
Weighted Average Exercise Price of Options Exercisable	0.77
Minimum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Price	0.25
Maximum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Price	$ 1.40

XML 41 R31.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of activity in issued and outstanding warrants - Warrants [Member]	9 Months Ended
	Nov. 30, 2020 $ / shares shares
Class of Warrant or Right [Line Items]
Number of Shares, Outstanding, February 29, 2020 \| shares	5,816,939
Exercise Prices, Outstanding, February 28, 2019 \| $ / shares	$ 1.40
Number of Shares, Granted \| shares
Exercise Prices, Granted \| $ / shares
Number of Shares,Exrecised \| shares
Exercise Prices, Exrecised \| $ / shares
Number of Shares, Cancelled \| shares
Exercise Prices, Cancelled \| $ / shares
Number of Shares, Outstanding, November 30, 2020 \| shares	5,816,939
Exercise Prices, Outstanding, November 30, 2020 \| $ / shares	$ 1.40

XML 42 R32.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details) - Schedule of exercise prices warrants outstanding - 1.40 [Member] - Warrant [Member]	9 Months Ended
	Nov. 30, 2020 $ / shares shares
Shareholders' Equity (Details) - Schedule of exercise prices warrants outstanding [Line Items]
Range of Exercise Prices	$ 1.40
Stock Warrants Outstanding (in Shares) \| shares	5,816,939
Stock Warrants Exercisable (in Shares) \| shares	5,816,939
Weighted Average Remaining Contractual Life	2 years 69 days
Weighted Average Exercise Price of Warrants Outstanding	$ 1.40
Weighted Average Exercise Price of Warrants Exercisable	$ 1.40

XML 43 R33.htm IDEA: XBRL DOCUMENT

Related Parties Transactions (Details) - USD ($)	1 Months Ended		9 Months Ended		12 Months Ended
Related Parties Transactions (Details) - USD ($)	Feb. 14, 2018	Jan. 24, 2017	Nov. 30, 2020	Nov. 30, 2019	Feb. 29, 2020
Related Parties Transactions (Details) [Line Items]
Notes payable-related party, non-current			$ 3,000,000		$ 3,000,000
Notes payable and accrued interest-related party			11,960,097		11,333,960
Accrued payroll and related expenses			1,008,000
Jiangsu Shengfeng [Member]
Related Parties Transactions (Details) [Line Items]
Companies return				$ 700,000
Principle loan amount			$ 700,000		700,000
Common Stock [Member]
Related Parties Transactions (Details) [Line Items]
Number of shares converted by notes (in Shares)	7,403,705
Mr. Breslow [Member]
Related Parties Transactions (Details) [Line Items]
Debt instrument principle amount		$ 23,872,614
Accrued interest on debt		8,890,574
Term of convertible note			5 years
Amount of convertible notes		$ 14,982,041	$ 3,000,000
Percentage of interest on notes			5.00%
Reverse stock split, description	1-for-7 reverse stock split
Amount of notes converted	$ 11,982,041
Accrued interest on convertible notes	$ 9,388,338		$ 375,925		375,925
Convertible rate price (in Dollars per share)			$ 1.40
Accrued interest-related party			$ 262,911		262,911
Mr. Breslow [Member] \| Convertible Note [Member]
Related Parties Transactions (Details) [Line Items]
Term of convertible note		5 years
Percentage of interest on notes		5.00%
Robert Kopple [Member]
Related Parties Transactions (Details) [Line Items]
Debt instrument principle amount			5,607,323		5,607,323
Accrued interest on notes			5,507,569		4,887,610
Balance of principle and accrued interest			$ 11,114,892		10,494,933
Related party transaction, description			the Company entered into an agreement with Robert Kopple, a former member of its Board of Directors for the sale of $2,500,000 of convertible notes payable (the “Kopple Notes”) and warrants. The Kopple Notes carried a base interest rate of 9.5%, have a 4-year maturity date and were convertible into shares of common stock at the conversion price of $3.50 per share (conversion feature expired in 2017). The warrants were subsequently exercised. The Company recorded $667,118 as a discount, which has been fully amortized. The Company also entered into a demand note payable with this individual in the amount of $20,000, which bears interest at a rate of 5% per annum.
Melvin Gagerman [Member] \| Unsecured Debt [Member]
Related Parties Transactions (Details) [Line Items]
Accrued interest on notes			$ 62,628
Unsecured note payable			82,000
Total amount of unsecured notes payable and accrued interest			$ 144,628		$ 139,026
Percentage of interest accrue			10.00%

XML 44 R34.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies (Details) shares in Millions	1 Months Ended			9 Months Ended
Commitments & Contingencies (Details) shares in Millions	Mar. 26, 2019 shares	Dec. 31, 2018 USD ($)	May 31, 2018 USD ($)	Nov. 30, 2020 USD ($) m²	Jul. 31, 2020 m²	Dec. 31, 2017 USD ($)
Commitments & Contingencies (Details) [Line Items]
Area of facility (in Square Meters) \| m²				1,000	20,000
Ongoing fees			$ 52,000
Moving and delivery amount		$ 114,000
Contingencies description	the Company controlling a combined total of more than 27.5 million shares delivered a signed written consent to the Company removing Ronald Buschur as a member of the Company’s Board and electing Cipora Lavut as a director of the Company.
Stockholders combined total (in Shares) \| shares	27.5
Stanton Facility [Member]
Commitments & Contingencies (Details) [Line Items]
Rent per month				$ 10,000
Storage Facility [Member]
Commitments & Contingencies (Details) [Line Items]
Rent per month				5,000
Offsite Storage Space [Member]
Commitments & Contingencies (Details) [Line Items]
Rent per month				$ 2,500
Office Space [Member]
Commitments & Contingencies (Details) [Line Items]
Area of facility (in Square Meters) \| m²				300
Rent per month				$ 2,350
Director [Member]
Commitments & Contingencies (Details) [Line Items]
Secured debt, description				The Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $11.1 million (representing approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced or paid to third parties on Aura’s behalf; and approximately $5 million Mr. Kopple claims to be owed for interest, loan fees and late payment charges) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company.
California labor board [Member]
Commitments & Contingencies (Details) [Line Items]
Accrued salary and related charges						$ 238,000

EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
-8?20$3;8T.P6BP^0"X99K>]9!:G-2=O2)&VYC"(Q8 QI@HHR7BV Y1?O^-D!0?*T5Z\ M/K6^R/ER;)\O]OZ]TK=SI6[)0R6DF42EM?5>')N\9!4UGU7-)+0LE*ZHA:*^ MB4VM&2U,R9BM1)P.!N.XHEQ&!_NKL:8Z]@O*LMQR):'255QS=F^>VUV1W''# MYUQPNYQ$[7_!(E)QR2O^R(I)-(B(*=7]=Z7YHY*6BEFNE1"3*.D:KIFV/']5 M/7.05W1NVAI+YY<40";1> #+K@VMNW1CD^!\8Y!YZ[46/6-"\OT,;7L5*NF MYO+�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end XML 46 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 169 310 1 false 50 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://aurasystems.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Balance Sheets (Unaudited) Sheet http://aurasystems.com/role/ConsolidatedBalanceSheet Condensed Balance Sheets (Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Balance Sheets (Unaudited) (Parentheticals) Sheet http://aurasystems.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Balance Sheets (Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://aurasystems.com/role/ConsolidatedIncomeStatement Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://aurasystems.com/role/ConsolidatedCashFlow Condensed Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Statements of Shareholders' Deficit (Unaudited) Sheet http://aurasystems.com/role/ShareholdersEquityType2or3 Condensed Statements of Shareholders' Deficit (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies Sheet http://aurasystems.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies Nature of Operations and Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Going Concern Sheet http://aurasystems.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 008 - Disclosure - Notes Payable Notes http://aurasystems.com/role/NotesPayable Notes Payable Notes 9 false false R10.htm 009 - Disclosure - Accrued Expenses Sheet http://aurasystems.com/role/AccruedExpenses Accrued Expenses Notes 10 false false R11.htm 010 - Disclosure - Shareholders' Equity Sheet http://aurasystems.com/role/ShareholdersEquity Shareholders' Equity Notes 11 false false R12.htm 011 - Disclosure - Related Parties Transactions Sheet http://aurasystems.com/role/RelatedPartiesTransactions Related Parties Transactions Notes 12 false false R13.htm 012 - Disclosure - Commitments & Contingencies Sheet http://aurasystems.com/role/CommitmentsContingencies Commitments & Contingencies Notes 13 false false R14.htm 013 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://aurasystems.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://aurasystems.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies 14 false false R15.htm 014 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Tables) Sheet http://aurasystems.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables Nature of Operations and Summary of Significant Accounting Policies (Tables) Tables http://aurasystems.com/role/NatureofOperationsandSummaryofSignificantAccountingPolicies 15 false false R16.htm 015 - Disclosure - Notes Payable (Tables) Notes http://aurasystems.com/role/NotesPayableTables Notes Payable (Tables) Tables http://aurasystems.com/role/NotesPayable 16 false false R17.htm 016 - Disclosure - Accrued Expenses (Tables) Sheet http://aurasystems.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://aurasystems.com/role/AccruedExpenses 17 false false R18.htm 017 - Disclosure - Shareholders' Equity (Tables) Sheet http://aurasystems.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://aurasystems.com/role/ShareholdersEquity 18 false false R19.htm 018 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Details) Sheet http://aurasystems.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesDetails Nature of Operations and Summary of Significant Accounting Policies (Details) Details http://aurasystems.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables 19 false false R20.htm 019 - Disclosure - Nature of Operations and Summary of Significant Accounting Policies (Details) - Schedule of earnings Per Share Sheet http://aurasystems.com/role/ScheduleofearningsPerShareTable Nature of Operations and Summary of Significant Accounting Policies (Details) - Schedule of earnings Per Share Details http://aurasystems.com/role/NatureofOperationsandSummaryofSignificantAccountingPoliciesTables 20 false false R21.htm 020 - Disclosure - Going Concern (Details) Sheet http://aurasystems.com/role/GoingConcernDetails Going Concern (Details) Details http://aurasystems.com/role/GoingConcern 21 false false R22.htm 021 - Disclosure - Notes Payable (Details) Notes http://aurasystems.com/role/NotesPayableDetails Notes Payable (Details) Details http://aurasystems.com/role/NotesPayableTables 22 false false R23.htm 022 - Disclosure - Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction Notes http://aurasystems.com/role/ScheduleofnonrelatedpartyandrelatedpartynotespayabletransactionTable Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction Details http://aurasystems.com/role/NotesPayableTables 23 false false R24.htm 023 - Disclosure - Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) Notes http://aurasystems.com/role/ScheduleofnonrelatedpartyandrelatedpartynotespayabletransactionTable_Parentheticals Notes Payable (Details) - Schedule of non-related party and related party notes payable transaction (Parentheticals) Details http://aurasystems.com/role/NotesPayableTables 24 false false R25.htm 024 - Disclosure - Accrued Expenses (Details) Sheet http://aurasystems.com/role/AccruedExpensesDetails Accrued Expenses (Details) Details http://aurasystems.com/role/AccruedExpensesTables 25 false false R26.htm 025 - Disclosure - Accrued Expenses (Details) - Schedule of accrued expenses Sheet http://aurasystems.com/role/ScheduleofaccruedexpensesTable Accrued Expenses (Details) - Schedule of accrued expenses Details http://aurasystems.com/role/AccruedExpensesTables 26 false false R27.htm 026 - Disclosure - Shareholders' Equity (Details) Sheet http://aurasystems.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://aurasystems.com/role/ShareholdersEquityTables 27 false false R28.htm 027 - Disclosure - Shareholders' Equity (Details) - Schedule of Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date Sheet http://aurasystems.com/role/ScheduleofBlackScholesMertonoptionmodeltodeterminethefairvalueofthestockoptionsasofthegrantdateTable Shareholders' Equity (Details) - Schedule of Black-Scholes Merton option model to determine the fair value of the stock options as of the grant date Details http://aurasystems.com/role/ShareholdersEquityTables 28 false false R29.htm 028 - Disclosure - Shareholders' Equity (Details) - Schedule of employee stock option plan Sheet http://aurasystems.com/role/ScheduleofemployeestockoptionplanTable Shareholders' Equity (Details) - Schedule of employee stock option plan Details http://aurasystems.com/role/ShareholdersEquityTables 29 false false R30.htm 029 - Disclosure - Shareholders' Equity (Details) - Schedule of exercise price options outstanding Sheet http://aurasystems.com/role/ScheduleofexercisepriceoptionsoutstandingTable Shareholders' Equity (Details) - Schedule of exercise price options outstanding Details http://aurasystems.com/role/ShareholdersEquityTables 30 false false R31.htm 030 - Disclosure - Shareholders' Equity (Details) - Schedule of activity in issued and outstanding warrants Sheet http://aurasystems.com/role/ScheduleofactivityinissuedandoutstandingwarrantsTable Shareholders' Equity (Details) - Schedule of activity in issued and outstanding warrants Details http://aurasystems.com/role/ShareholdersEquityTables 31 false false R32.htm 031 - Disclosure - Shareholders' Equity (Details) - Schedule of exercise prices warrants outstanding Sheet http://aurasystems.com/role/ScheduleofexercisepriceswarrantsoutstandingTable Shareholders' Equity (Details) - Schedule of exercise prices warrants outstanding Details http://aurasystems.com/role/ShareholdersEquityTables 32 false false R33.htm 032 - Disclosure - Related Parties Transactions (Details) Sheet http://aurasystems.com/role/RelatedPartiesTransactionsDetails Related Parties Transactions (Details) Details http://aurasystems.com/role/RelatedPartiesTransactions 33 false false R34.htm 033 - Disclosure - Commitments & Contingencies (Details) Sheet http://aurasystems.com/role/CommitmentsContingenciesDetails Commitments & Contingencies (Details) Details http://aurasystems.com/role/CommitmentsContingencies 34 false false All Reports Book All Reports ausi-20201130.xml ausi-20201130.xsd ausi-20201130_cal.xml ausi-20201130_def.xml ausi-20201130_lab.xml ausi-20201130_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 true true ZIP 50 0001213900-21-002805-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-21-002805-xbrl.zip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

Shareholders' Equity (Details) - Schedule of activity in issued and outstanding warrants - Warrants [Member]	9 Months Ended
	Nov. 30, 2020 $ / shares shares
Class of Warrant or Right [Line Items]
Number of Shares, Outstanding, February 29, 2020 \| shares	5,816,939
Exercise Prices, Outstanding, February 28, 2019 \| $ / shares	$ 1.40
Number of Shares, Granted \| shares
Exercise Prices, Granted \| $ / shares
Number of Shares,Exrecised \| shares
Exercise Prices, Exrecised \| $ / shares
Number of Shares, Cancelled \| shares
Exercise Prices, Cancelled \| $ / shares
Number of Shares, Outstanding, November 30, 2020 \| shares	5,816,939
Exercise Prices, Outstanding, November 30, 2020 \| $ / shares	$ 1.40